HIV	O
does	O
not	O
replicate	O
in	O
naive	B-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
stimulated	O
with	O
CD3/CD28	B-protein
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
T	O
cell	O
tropic	O
strain	O
of	O
HIV	O
,	O
LAI	O
,	O
does	O
not	O
replicate	O
in	O
naive	B-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
stimulated	O
by	O
cross-linking	O
CD3	B-protein
and	O
CD28	B-protein
.	O

In	O
contrast	O
,	O
LAI	O
replicates	O
well	O
in	O
memory	B-cell_type
CD4	I-cell_type
T	I-cell_type
cells	I-cell_type
stimulated	O
in	O
the	O
same	O
way	O
.	O

Unlike	O
this	O
physiologically	O
relevant	O
stimulation	O
,	O
PHA	B-protein
stimulates	O
productive	O
LAI	O
replication	O
in	O
both	O
naive	B-cell_type
and	I-cell_type
memory	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

These	O
studies	O
were	O
conducted	O
with	O
highly	O
purified	O
(	O
FACS-isolated	O
)	O
subsets	O
of	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
identified	O
by	O
expression	O
of	O
both	O
CD45RA	B-protein
and	O
CD62L	B-protein
.	O

Remixing	O
of	O
purified	B-cell_type
T	I-cell_type
cells	I-cell_type
showed	O
that	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
do	O
not	O
suppress	O
LAI	O
replication	O
in	O
memory	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
that	O
memory	B-cell_type
T	I-cell_type
cells	I-cell_type
do	O
not	O
restore	O
LAI	O
expression	O
in	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
suppression	O
of	O
productive	O
LAI	O
replication	O
in	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
is	O
not	O
due	O
to	O
differential	O
expression	O
of	O
viral	B-protein
coreceptors	I-protein
,	O
nor	O
is	O
it	O
due	O
to	O
inhibition	O
of	O
activation	O
of	O
the	O
important	O
HIV	O
transcription	B-protein
factors	I-protein
,	O
nuclear	B-protein
factor-kappaB	I-protein
and	O
activator	B-protein
protein-1	I-protein
.	O

The	O
inherent	O
resistance	O
of	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
productive	O
HIV	O
infection	O
,	O
coupled	O
with	O
their	O
proliferative	O
advantage	O
as	O
demonstrated	O
here	O
,	O
provides	O
a	O
sound	O
basis	O
for	O
proposed	O
clinical	O
therapies	O
using	O
ex	O
vivo	O
expansion	O
and	O
reinfusion	O
of	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
from	O
HIV-infected	O
adults	O
.	O

HIV	NULL
Does	NULL
Not	NULL
Replicate	NULL
in	NULL
Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Stimulated	NULL
with	NULL
CD3/CD28	NULL
Mario	NULL
Roederer	NULL
,	NULL
Paul	NULL
A.	NULL
Raju	NULL
,	NULL
Dipendra	NULL
K.	NULL
Mitra	NULL
,	NULL
Leonore	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
Leonard	NULL
A.	NULL
Herzenberg	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305-5125	NULL
Abstract	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
T	NULL
cell	NULL
tropic	NULL
strain	NULL
of	NULL
HIV	NULL
,	NULL
LAI	NULL
,	NULL
does	NULL
not	NULL
replicate	NULL
in	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
stimulated	NULL
by	NULL
cross-linking	NULL
CD3	NULL
and	NULL
CD28	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LAI	NULL
replicates	NULL
well	NULL
in	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
stimulated	NULL
in	NULL
the	NULL
same	NULL
way	NULL
.	NULL

Unlike	NULL
this	NULL
physiologically	NULL
relevant	NULL
stimulation	NULL
,	NULL
PHA	NULL
stimulates	NULL
productive	NULL
LAI	NULL
replication	NULL
in	NULL
both	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
conducted	NULL
with	NULL
highly	NULL
purified	NULL
(	NULL
FACS®-isolated	NULL
)	NULL
subsets	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
identified	NULL
by	NULL
expression	NULL
of	NULL
both	NULL
CD45RA	NULL
and	NULL
CD62L	NULL
.	NULL

Remixing	NULL
of	NULL
purified	NULL
T	NULL
cells	NULL
showed	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
suppress	NULL
LAI	NULL
replication	NULL
in	NULL
memory	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
memory	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
restore	NULL
LAI	NULL
expression	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
suppression	NULL
of	NULL
productive	NULL
LAI	NULL
replication	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
differential	NULL
expression	NULL
of	NULL
viral	NULL
coreceptors	NULL
,	NULL
nor	NULL
is	NULL
it	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
important	NULL
HIV	NULL
transcription	NULL
factors	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
and	NULL
activator	NULL
protein-1	NULL
.	NULL

The	NULL
inherent	NULL
resistance	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
to	NULL
productive	NULL
HIV	NULL
infection	NULL
,	NULL
coupled	NULL
with	NULL
their	NULL
proliferative	NULL
advantage	NULL
as	NULL
demonstrated	NULL
here	NULL
,	NULL
provides	NULL
a	NULL
sound	NULL
basis	NULL
for	NULL
proposed	NULL
clinical	NULL
therapies	NULL
using	NULL
ex	NULL
vivo	NULL
expansion	NULL
and	NULL
reinfusion	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
HIV-infected	NULL
adults	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1997	NULL
.	NULL

99	NULL
:	NULL
1555-1564	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
nuclear	NULL
factor-kB	NULL
«	NULL
T	NULL
cell	NULL
proliferation	NULL
«	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
«	NULL
human	NULL
immunodeficiency	NULL
coreceptors	NULL
«	NULL
stromal-derived	NULL
factor-1	NULL
Introduction	NULL
The	NULL
replication	NULL
of	NULL
HIV	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
tightly	NULL
linked	NULL
to	NULL
the	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
is	NULL
necessary	NULL
for	NULL
productive	NULL
infection	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
greater	NULL
T	NULL
cell	NULL
proliferation	NULL
is	NULL
generally	NULL
believed	NULL
to	NULL
lead	NULL
to	NULL
greater	NULL
viral	NULL
replication	NULL
.	NULL

This	NULL
is	NULL
the	NULL
case	NULL
when	NULL
bulk	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
such	NULL
as	NULL
those	NULL
found	NULL
in	NULL
unseparated	NULL
PBMC	NULL
)	NULL
are	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL

However	NULL
,	NULL
as	NULL
we	NULL
show	NULL
in	NULL
this	NULL
report	NULL
,	NULL
this	NULL
paradigm	NULL
breaks	NULL
down	NULL
when	NULL
purified	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
are	NULL
studied	NULL
.	NULL

T	NULL
cells	NULL
in	NULL
PBMC	NULL
are	NULL
extremely	NULL
heterogeneous	NULL
,	NULL
both	NULL
functionally	NULL
and	NULL
phenotypically	NULL
.	NULL

They	NULL
can	NULL
be	NULL
broadly	NULL
divided	NULL
into	NULL
``	NULL
naive	NULL
``	NULL
and	NULL
``	NULL
memory	NULL
``	NULL
subsets	NULL
:	NULL
naive	NULL
are	NULL
those	NULL
cells	NULL
that	NULL
have	NULL
not	NULL
yet	NULL
encountered	NULL
their	NULL
cognate	NULL
antigen	NULL
,	NULL
and	NULL
memory	NULL
cells	NULL
are	NULL
those	NULL
that	NULL
have	NULL
previously	NULL
undergone	NULL
an	NULL
antigen-driven	NULL
Address	NULL
correspondence	NULL
to	NULL
Mario	NULL
Roederer	NULL
,	NULL
Beckman	NULL
BO11	NULL
,	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305-5125	NULL
.	NULL

Phone	NULL
:	NULL
415-723-7149	NULL
;	NULL
FAX	NULL
:	NULL
415-725-8564	NULL
;	NULL
E-mail	NULL
:	NULL
roederer	NULL
@	NULL
darwin	NULL
.	NULL

stanford.edu	NULL
Received	NULL
for	NULL
publication	NULL
6	NULL
September	NULL
1996	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
19	NULL
December	NULL
1996	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/97/04/1555/10	NULL
$	NULL
2.00	NULL
Volume	NULL
99	NULL
,	NULL
Number	NULL
7	NULL
,	NULL
April	NULL
1997	NULL
,	NULL
1555-1564	NULL
expansion	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
are	NULL
phenotypically	NULL
identified	NULL
as	NULL
coexpressing	NULL
CD45RA	NULL
and	NULL
CD62L	NULL
,	NULL
while	NULL
lacking	NULL
expression	NULL
of	NULL
CD45RO	NULL
,	NULL
activation	NULL
markers	NULL
,	NULL
and	NULL
only	NULL
poorly	NULL
expressing	NULL
CD11a	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Functionally	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
also	NULL
distinct	NULL
from	NULL
memory	NULL
cells	NULL
:	NULL
they	NULL
respond	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
with	NULL
a	NULL
greater	NULL
calcium	NULL
flux	NULL
,	NULL
greater	NULL
proliferation	NULL
,	NULL
and	NULL
a	NULL
much	NULL
more	NULL
restricted	NULL
cytokine	NULL
profile	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
mildly	NULL
resistant	NULL
to	NULL
HIV	NULL
infection	NULL
in	NULL
vitro	NULL
and	NULL
to	NULL
harbor	NULL
less	NULL
virus	NULL
in	NULL
infected	NULL
patients	NULL
in	NULL
vivo	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
used	NULL
only	NULL
CD45RA	NULL
or	NULL
CD45RO	NULL
to	NULL
distinguish	NULL
naive	NULL
from	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

While	NULL
this	NULL
phenotyping	NULL
is	NULL
relatively	NULL
specific	NULL
,	NULL
it	NULL
is	NULL
not	NULL
adequate	NULL
for	NULL
functional	NULL
studies	NULL
such	NULL
as	NULL
those	NULL
presented	NULL
here	NULL
.	NULL

In	NULL
healthy	NULL
individuals	NULL
,	NULL
on	NULL
average	NULL
,	NULL
5	NULL
%	NULL
of	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
express	NULL
CD45RA	NULL
but	NULL
not	NULL
CD4SRO	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
CD62L	NULL
and	NULL
the	NULL
coexpression	NULL
of	NULL
other	NULL
memory	NULL
phenotype	NULL
markers	NULL
such	NULL
as	NULL
CD57	NULL
.	NULL

This	NULL
percentage	NULL
increases	NULL
significantly	NULL
during	NULL
the	NULL
progression	NULL
of	NULL
HIV	NULL
disease	NULL
,	NULL
such	NULL
that	NULL
in	NULL
advanced	NULL
stage	NULL
patients	NULL
,	NULL
a	NULL
vast	NULL
majority	NULL
of	NULL
CD45RA+	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
memory	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
half	NULL
of	NULL
the	NULL
peripheral	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
healthy	NULL
adult	NULL
are	NULL
naive	NULL
.	NULL

Therefore	NULL
,	NULL
using	NULL
only	NULL
CD4SRA	NULL
(	NULL
or	NULL
CD45RO	NULL
)	NULL
to	NULL
isolate	NULL
naive	NULL
T	NULL
cells	NULL
will	NULL
lead	NULL
to	NULL
an	NULL
average	NULL
contamination	NULL
with	NULL
memory	NULL
T	NULL
cells	NULL
of	NULL
at	NULL
least	NULL
10	NULL
%	NULL
.	NULL

Since	NULL
memory	NULL
T	NULL
cells	NULL
are	NULL
very	NULL
different	NULL
functionally	NULL
from	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
such	NULL
a	NULL
large	NULL
contamination	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
inappropriate	NULL
assignment	NULL
of	NULL
memory-derived	NULL
cell	NULL
functions	NULL
to	NULL
the	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
use	NULL
three-color	NULL
FACS®	NULL
to	NULL
uniquely	NULL
identify	NULL
and	NULL
isolate	NULL
naive	NULL
T	NULL
cells	NULL
based	NULL
on	NULL
the	NULL
combined	NULL
phenotype	NULL
of	NULL
CD4	NULL
,	NULL
CD45RA	NULL
,	NULL
and	NULL
CD62L	NULL
,	NULL
resulting	NULL
in	NULL
highly	NULL
pure	NULL
,	NULL
homogeneous	NULL
cell	NULL
popula-tions	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
there	NULL
is	NULL
an	NULL
important	NULL
difference	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
,	NULL
a	NULL
difference	NULL
far	NULL
greater	NULL
than	NULL
had	NULL
been	NULL
recognized	NULL
previously	NULL
.	NULL

In	NULL
response	NULL
to	NULL
cross-linking	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
,	NULL
which	NULL
mimics	NULL
physiological	NULL
signals	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
completely	NULL
suppress	NULL
HIV	NULL
replication	NULL
while	NULL
memory	NULL
T	NULL
cells	NULL
support	NULL
active	NULL
replication	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
purified	NULL
T	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
little	NULL
correlation	NULL
between	NULL
the	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
and	NULL
the	NULL
replication	NULL
of	NULL
HIV	NULL
in	NULL
those	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
particularly	NULL
important	NULL
for	NULL
the	NULL
design	NULL
and	NULL
implementation	NULL
of	NULL
ex	NULL
vivo	NULL
CD4	NULL
T	NULL
cell	NULL
expansion	NULL
for	NULL
cell-based	NULL
therapy	NULL
of	NULL
HIV	NULL
disease	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Methods	NULL
Standard	NULL
conditions	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
humidified	NULL
CO	NULL
,	NULL
incubator	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gemini	NULL
Bioproducts	NULL
,	NULL
Inc.	NULL
,	NULL
Calabasas	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
L-glutamine	NULL
(	NULL
290	NULL
pg/ml	NULL
!	NULL
)	NULL

,	NULL
penicillin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
70	NULL
pg/ml	NULL
!	NULL
)	NULL

,	NULL
and	NULL
recombinant	NULL
IL-2	NULL
(	NULL
25	NULL
U/ml	NULL
)	NULL
(	NULL
complete	NULL
RPMI	NULL
)	NULL
.	NULL

P815/B7	NULL
(	NULL
kind	NULL
gift	NULL
of	NULL
Lewis	NULL
Lanier	NULL
,	NULL
DNAX	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

PHA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
used	NULL
at	NULL
2	NULL
pg/ml	NULL
,	NULL
and	NULL
Leu4	NULL
(	NULL
anti-CD3	NULL
monoclonal	NULL
antibody	NULL
;	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
50	NULL
ng/ml	NULL
.	NULL

For	NULL
coculture	NULL
,	NULL
P815/B7	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
0.5	NULL
%	NULL
paraformalde-hyde	NULL
for	NULL
10	NULL
min	NULL
and	NULL
washed	NULL
extensively	NULL
with	NULL
RPMI	NULL
.	NULL

Fixed	NULL
P815/B7	NULL
Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Suppress	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
1555	NULL
were	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10°	NULL
cells/ml	NULL
to	NULL
cell	NULL
cultures	NULL
.	NULL

Control	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
fixed	NULL
P815	NULL
cells	NULL
(	NULL
that	NULL
do	NULL
not	NULL
express	NULL
the	NULL
B7	NULL
antigen	NULL
)	NULL
to	NULL
prove	NULL
that	NULL
the	NULL
fixed	NULL
cells	NULL
contributed	NULL
no	NULL
signaling	NULL
other	NULL
than	NULL
the	NULL
B7/CD28	NULL
interaction	NULL
and	NULL
the	NULL
cross-linking	NULL
of	NULL
soluble	NULL
Leud4	NULL
.	NULL

Isolation	NULL
of	NULL
PBMC	NULL
.	NULL

All	NULL
human	NULL
peripheral	NULL
blood	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
Ficol-separated	NULL
buffy	NULL
coats	NULL
obtained	NULL
from	NULL
HIV-	NULL
and	NULL
hep-atitis-seronegative	NULL
anonymous	NULL
donors	NULL
at	NULL
the	NULL
Stanford	NULL
Blood	NULL
Bank	NULL
.	NULL

After	NULL
density	NULL
centrifugation	NULL
,	NULL
PBMCs	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
at	NULL
3	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
complete	NULL
RPMI	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
Nonadherent	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
between	NULL
1	NULL
and	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
antibodies	NULL
for	NULL
sorting	NULL
.	NULL

Cell	NULL
staining	NULL
,	NULL
flow	NULL
sorting	NULL
,	NULL
and	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
FITC	NULL
CD62L	NULL
,	NULL
PE	NULL
CD45RA	NULL
,	NULL
CySPE	NULL
CD4	NULL
,	NULL
or	NULL
Cy5PE	NULL
CD8	NULL
(	NULL
PharMin-gen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
room	NULL
temperature	NULL
medium	NULL
,	NULL
and	NULL
sorted	NULL
by	NULL
FACS®	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
at	NULL
least	NULL
10°	NULL
cells	NULL
of	NULL
a	NULL
particular	NULL
phenotype	NULL
were	NULL
sorted	NULL
.	NULL

For	NULL
subsequent	NULL
reanalyses	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
on	NULL
ice	NULL
.	NULL

For	NULL
Hoechst	NULL
33342	NULL
staining	NULL
(	NULL
10	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
medium	NULL
containing	NULL
2	NULL
pg/ml	NULL
Hoechst	NULL
33342	NULL
at	NULL
37°C	NULL
for	NULL
7	NULL
min	NULL
.	NULL

Staining	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
vol	NULL
cold	NULL
medium	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
stained	NULL
for	NULL
antibodies	NULL
.	NULL

Before	NULL
reanalysis	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
fixed	NULL
with	NULL
0.5	NULL
%	NULL
paraformaldehyde	NULL
.	NULL

In	NULL
general	NULL
,	NULL
30,000	NULL
events	NULL
were	NULL
collected	NULL
for	NULL
reanalysis	NULL
.	NULL

A	NULL
FACStarPlus®	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
)	NULL
equipped	NULL
with	NULL
two	NULL
argon	NULL
ion	NULL
lasers	NULL
(	NULL
488	NULL
and	NULL
351	NULL
nm	NULL
excitation	NULL
)	NULL
was	NULL
used	NULL
for	NULL
sorting	NULL
and	NULL
analysis	NULL
.	NULL

Acute	NULL
HIV	NULL
infection	NULL
.	NULL

24	NULL
h	NULL
before	NULL
infection	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
ACH-2	NULL
cells	NULL
(	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
chronically	NULL
and	NULL
productively	NULL
infected	NULL
with	NULL
an	NULL
LAI	NULL
HIV	NULL
isolate	NULL
,	NULL
reference	NULL
11	NULL
)	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
medium	NULL
were	NULL
stimulated	NULL
with	NULL
TNFa	NULL
,	NULL
1	NULL
ng/ml	NULL
,	NULL
and	NULL
PMA	NULL
,	NULL
2	NULL
ng/ml	NULL
for	NULL
1	NULL
h	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
ACH-2	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
to	NULL
remove	NULL
residual	NULL
stimulants	NULL
and	NULL
cultured	NULL
for	NULL
23	NULL
h.	NULL
Supernatants	NULL
were	NULL
assayed	NULL
for	NULL
residual	NULL
PMA	NULL
and	NULL
TNFa	NULL
to	NULL
assure	NULL
complete	NULL
removal	NULL
of	NULL
these	NULL
stimulants	NULL
.	NULL

Cells	NULL
to	NULL
be	NULL
infected	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
ACH-2	NULL
supernatant	NULL
,	NULL
500	NULL
pl	NULL
per	NULL
10°	NULL
cells	NULL
(	NULL
approximate	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
3	NULL
)	NULL
,	NULL
and	NULL
polybrene	NULL
(	NULL
3	NULL
pg/ml	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
cultured	NULL
at	NULL
4	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
appropriately	NULL
supplemented	NULL
RPMI	NULL
.	NULL

Infection	NULL
was	NULL
monitored	NULL
at	NULL
various	NULL
time	NULL
points	NULL
by	NULL
removing	NULL
50	NULL
pl	NULL
of	NULL
supernatant	NULL
as	NULL
assaying	NULL
for	NULL
p24	NULL
antigen	NULL
,	NULL
using	NULL
an	NULL
enzyme-linked	NULL
immunoad-sorbent	NULL
assay	NULL
(	NULL
Abbott	NULL
Laboratories	NULL
Diagnostic	NULL
Division	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
a	NULL
standard	NULL
curve	NULL
was	NULL
generated	NULL
for	NULL
known	NULL
concentrations	NULL
of	NULL
p24	NULL
to	NULL
determine	NULL
the	NULL
absolute	NULL
concentration	NULL
in	NULL
samples	NULL
.	NULL

Semiquantitative	NULL
PCR	NULL
for	NULL
CXC	NULL
chemokine	NULL
receptor	NULL
4	NULL
and	NULL
CC	NULL
chemokine	NULL
receptor	NULL
5	NULL
.	NULL

RNA	NULL
from	NULL
250,000	NULL
sorted	NULL
cells	NULL
(	NULL
naive	NULL
or	NULL
memory	NULL
)	NULL
was	NULL
isolated	NULL
using	NULL
RNAzo	NULL
!	NULL

B	NULL
(	NULL
TelTest	NULL
,	NULL
Inc.	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Total	NULL
cDNA	NULL
was	NULL
synthesized	NULL
using	NULL
1	NULL
g	NULL
random	NULL
hexamers	NULL
in	NULL
a	NULL
35-ul	NULL
reaction	NULL
volume	NULL
.	NULL

3	NULL
pl	NULL
of	NULL
each	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
each	NULL
gene	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
each	NULL
PCR	NULL
reaction	NULL
was	NULL
removed	NULL
after	NULL
25	NULL
,	NULL
30	NULL
,	NULL
35	NULL
,	NULL
and	NULL
40	NULL
cycles	NULL
.	NULL

Products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
stain-ing	NULL
.	NULL

Quantitation	NULL
was	NULL
performed	NULL
on	NULL
digital	NULL
images	NULL
of	NULL
the	NULL
gel	NULL
;	NULL
results	NULL
are	NULL
presented	NULL
from	NULL
aliquots	NULL
taken	NULL
while	NULL
the	NULL
amplification	NULL
was	NULL
still	NULL
proceeding	NULL
exponentially	NULL
.	NULL

The	NULL
following	NULL
primer	NULL
pairs	NULL
were	NULL
used	NULL
:	NULL
B-actin	NULL
,	NULL
TGACGGGGTCACCCACACTGTGCCCATCTA	NULL
and	NULL
CTAGA-AGCATTGCGGTGGACGATGGAGGG	NULL
;	NULL
CXC	NULL
chemokine	NULL
receptor	NULL
4	NULL
(	NULL
CXCR-4	NULL
)	NULL
'	NULL
,	NULL
GCAGCAGGTAGCAAAGTGAC	NULL
and	NULL
CGTTC-CACGGGAATGGAGAG	NULL
;	NULL
CC	NULL
chemokine	NULL
receptor	NULL
5	NULL
(	NULL
CCR-5	NULL
)	NULL
,	NULL
CAAGCTGCTTCTGGTTGGGC	NULL
and	NULL
GCCTCAGCCCAGGTGA-ACCC	NULL
.	NULL

Chemokine-induced	NULL
calcium	NULL
flux	NULL
.	NULL

Naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
were	NULL
sorted	NULL
and	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
IL-2	NULL
under	NULL
standard	NULL
conditions	NULL
.	NULL

Cells	NULL
1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
CCR-5	NULL
,	NULL
``	NULL
CC	NULL
``	NULL
chemokine	NULL
receptor	NULL
5	NULL
;	NULL
CXCR-4	NULL
,	NULL
``	NULL
CXC	NULL
``	NULL
chemokine	NULL
receptor	NULL
4	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
;	NULL
SDF	NULL
,	NULL
stromal-derived	NULL
factor	NULL
.	NULL

1556	NULL
-	NULL
Roederer	NULL
etal	NULL
.	NULL

were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Indo-1	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Inc.	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
3	NULL
M	NULL
;	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
``	NULL
load	NULL
``	NULL
buffer	NULL
(	NULL
HBSS	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
fetal	NULL
calf	NULL
se-rum	NULL
)	NULL
.	NULL

For	NULL
each	NULL
sample	NULL
condition	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
diluted	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
2	NULL
ml	NULL
in	NULL
``	NULL
flux	NULL
``	NULL
buffer	NULL
(	NULL
HBSS	NULL
supplemented	NULL
with	NULL
1.6	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.3	NULL
)	NULL
,	NULL
and	NULL
placed	NULL
in	NULL
a	NULL
fluorom-etry	NULL
cuvette	NULL
with	NULL
a	NULL
magnetic	NULL
stir	NULL
bar	NULL
.	NULL

Indo-1	NULL
fluorescence	NULL
was	NULL
continuously	NULL
monitored	NULL
at	NULL
two	NULL
wavelengths	NULL
(	NULL
400	NULL
and	NULL
490	NULL
nm	NULL
)	NULL
;	NULL
the	NULL
ratio	NULL
is	NULL
monotonically	NULL
related	NULL
to	NULL
calcium	NULL
concentration	NULL
.	NULL

Highly	NULL
purified	NULL
,	NULL
recombinant	NULL
SDF-1	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Inc.	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
250	NULL
pM	NULL
after	NULL
collection	NULL
of	NULL
resting	NULL
Indo-1	NULL
fluorescence	NULL
.	NULL

Collection	NULL
was	NULL
continued	NULL
for	NULL
several	NULL
more	NULL
minutes	NULL
.	NULL

Proliferative	NULL
responses	NULL
.	NULL

Bulk	NULL
PBMCs	NULL
and	NULL
sorted	NULL
subpopulations	NULL
(	NULL
either	NULL
HIV-	NULL
or	NULL
mock-infected	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
200-ul	NULL
volumes	NULL
of	NULL
a	NULL
96-well	NULL
plate	NULL
in	NULL
triplicate	NULL
(	NULL
10+	NULL
cells/well	NULL
)	NULL
.	NULL

3	NULL
d	NULL
after	NULL
stimulation	NULL
,	NULL
1.Ci	NULL
of	NULL
*H-thymidine	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
.	NULL

24	NULL
h	NULL
later	NULL
,	NULL
incorporated	NULL
radioactivity	NULL
was	NULL
determined	NULL
using	NULL
an	NULL
automated	NULL
harvesting	NULL
and	NULL
counting	NULL
system	NULL
.	NULL

Quantitative	NULL
competitive	NULL
PCR	NULL
for	NULL
cytokine	NULL
expression	NULL
.	NULL

mRNA	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
y-IFN	NULL
were	NULL
quantitated	NULL
by	NULL
quantitative	NULL
competitive	NULL
PCR	NULL
(	NULL
13	NULL
)	NULL
;	NULL
the	NULL
method	NULL
will	NULL
be	NULL
presented	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
Mitra	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Tung	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
M.	NULL
Roederer	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
competitor	NULL
in	NULL
each	NULL
case	NULL
was	NULL
an	NULL
artificially	NULL
constructed	NULL
RNA	NULL
containing	NULL
the	NULL
precise	NULL
cytokine	NULL
mRNA	NULL
sequence	NULL
but	NULL
with	NULL
an	NULL
internal	NULL
deletion	NULL
.	NULL

These	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
amplification	NULL
using	NULL
a	NULL
5	NULL
'	NULL
primer	NULL
that	NULL
is	NULL
homolo-gous	NULL
to	NULL
two	NULL
portions	NULL
of	NULL
each	NULL
gene	NULL
69	NULL
,	NULL
85	NULL
,	NULL
and	NULL
87	NULL
bp	NULL
apart	NULL
(	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
y-IFN	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
together	NULL
with	NULL
a	NULL
3	NULL
'	NULL
primer	NULL
near	NULL
the	NULL
terminus	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
also	NULL
contains	NULL
the	NULL
T7	NULL
RNA	NULL
polymerase	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
the	NULL
sequences	NULL
given	NULL
below	NULL
,	NULL
underlined	NULL
regions	NULL
are	NULL
the	NULL
T7	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
the	NULL
asterisk	NULL
(	NULL
-*-	NULL
)	NULL
marks	NULL
the	NULL
position	NULL
where	NULL
the	NULL
primer	NULL
bridges	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
mRNA	NULL
sequence	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

Primers	NULL
used	NULL
were	NULL
:	NULL
IL-2	NULL
,	NULL
TAATACGACTCACTATAGGG-ATGTACAGGATGCAACTCCTGTCT-*-CTACAACTGGAG-	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
GTATCTATGTAGATTGGTTAG	NULL
(	NULL
3	NULL
'	NULL
)	NULL
;	NULL
IL-4	NULL
,	NULL
TAATACGACTCACTATAGGG-ATGGGTTCTCAC-CTCCCAACTGCT-*-CTGTGCACCGAGTTGACC	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
CCT-GTGAAGGAAGCCAACCAGAGT	NULL
(	NULL
3	NULL
'	NULL
)	NULL
;	NULL
y-IFN	NULL
,	NULL
TAATACGAC-TCACTATAGGG-ATGAAATATACAAGTTATATCTTGGC-	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
CTA-AGCAAGATCCCATGGGTTGTGTGT	NULL
(	NULL
3	NULL
'	NULL
)	NULL
.	NULL

These	NULL
primers	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
total	NULL
cDNA	NULL
from	NULL
PHA-stimulated	NULL
PBMC	NULL
.	NULL

The	NULL
product	NULL
bands	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
used	NULL
as	NULL
substrates	NULL
for	NULL
in	NULL
vitro	NULL
RNA	NULL
synthesis	NULL
.	NULL

The	NULL
resulting	NULL
full	NULL
length	NULL
RNA	NULL
was	NULL
quantitated	NULL
spectropho-tometrically	NULL
and	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
a	NULL
known	NULL
number	NULL
of	NULL
molecules	NULL
per	NULL
microliter	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
mRNA	NULL
messages	NULL
from	NULL
the	NULL
sorted	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
mRNA	NULL
was	NULL
isolated	NULL
as	NULL
above	NULL
.	NULL

Seven	NULL
aliquots	NULL
,	NULL
each	NULL
containing	NULL
10	NULL
%	NULL
of	NULL
the	NULL
total	NULL
mRNA	NULL
,	NULL
were	NULL
mixed	NULL
with	NULL
known	NULL
amounts	NULL
of	NULL
each	NULL
cytokine	NULL
deletion	NULL
transcript	NULL
(	NULL
half-log	NULL
dilutions	NULL
starting	NULL
at	NULL
1.3	NULL
X	NULL
10°	NULL
copies	NULL
of	NULL
AIL-2	NULL
,	NULL
10°	NULL
copies	NULL
of	NULL
AIL-4	NULL
,	NULL
and	NULL
10°	NULL
copies	NULL
of	NULL
Ay-IFN	NULL
)	NULL
.	NULL

cDNA	NULL
from	NULL
each	NULL
mixture	NULL
was	NULL
synthesized	NULL
as	NULL
above	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
each	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
nested	NULL
primers	NULL
specific	NULL
for	NULL
each	NULL
cytokine	NULL
message	NULL
.	NULL

Products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
stain-ing	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
wild-type	NULL
mRNA	NULL
(	NULL
cell	NULL
derived	NULL
)	NULL
and	NULL
deleted	NULL
RNA	NULL
(	NULL
standard	NULL
)	NULL
were	NULL
performed	NULL
by	NULL
image	NULL
analysis	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
size-corrected	NULL
intensities	NULL
were	NULL
recorded	NULL
(	NULL
13	NULL
)	NULL
.	NULL

These	NULL
values	NULL
were	NULL
used	NULL
to	NULL
compute	NULL
the	NULL
number	NULL
of	NULL
molecules	NULL
of	NULL
each	NULL
mRNA	NULL
per	NULL
cell	NULL
.	NULL

The	NULL
following	NULL
nested	NULL
primers	NULL
were	NULL
used	NULL
:	NULL
IL-2	NULL
,	NULL
ATGTACAGGATG-CAACTCCTGTCT	NULL
and	NULL
TCAAAGCATCATCTCAACACTAAC	NULL
,	NULL
IL-4	NULL
,	NULL
ATGGGTTCTCACCTCCCAACTGCT	NULL
and	NULL
CCTGTGAAG-GAAGCCAACCAGAGT	NULL
,	NULL
y-IFN	NULL
,	NULL
ATGAAATATACAAGTTAT	NULL
ATCTTGGCTTT	NULL
and	NULL
ATGCTGTTTCGAGGTCGAAGAGCATC	NULL
.	NULL

The	NULL
amplified	NULL
product	NULL
sizes	NULL
for	NULL
each	NULL
gene	NULL
and	NULL
its	NULL
deletion	NULL
construct	NULL
are	NULL
:	NULL
IL-2	NULL
,	NULL
460	NULL
and	NULL
391	NULL
bp	NULL
;	NULL
IL-4	NULL
,	NULL
383	NULL
and	NULL
278	NULL
bp	NULL
;	NULL
y-IFN	NULL
,	NULL
496	NULL
and	NULL
409	NULL
bp	NULL
.	NULL

Quantitative	NULL
PCR	NULL
for	NULL
HIV	NULL
DNA	NULL
and/or	NULL
RNA	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
these	NULL
experiments	NULL
,	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
were	NULL
sorted	NULL
,	NULL
cultured	NULL
,	NULL
and	NULL
infected	NULL
with	NULL
HIV	NULL
as	NULL
described	NULL
above	NULL
.	NULL

20	NULL
h	NULL
after	NULL
infection	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
growth	NULL
medium	NULL
,	NULL
and	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
later	NULL
dissolved	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
HIV-containing	NULL
supernatant	NULL
and	NULL
immediately	NULL
washed	NULL
and	NULL
frozen	NULL
.	NULL

These	NULL
samples	NULL
had	NULL
<	NULL
20	NULL
%	NULL
of	NULL
the	NULL
signal	NULL
from	NULL
the	NULL
20-h	NULL
cultures	NULL
.	NULL

HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
lacZ	NULL
reporter	NULL
cell	NULL
assay	NULL
.	NULL

The	NULL
development	NULL
,	NULL
properties	NULL
,	NULL
and	NULL
application	NULL
of	NULL
the	NULL
293.27.2	NULL
cell	NULL
line	NULL
have	NULL
been	NULL
published	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Support	NULL
medium	NULL
for	NULL
experiments	NULL
and	NULL
maintenance	NULL
of	NULL
cells	NULL
was	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
)	NULL
.	NULL

For	NULL
a	NULL
typical	NULL
experiment	NULL
,	NULL
2,000	NULL
cells	NULL
per	NULL
well	NULL
were	NULL
plated	NULL
12-24	NULL
h	NULL
before	NULL
the	NULL
experiment	NULL
.	NULL

Supernatants	NULL
from	NULL
cultures	NULL
were	NULL
applied	NULL
to	NULL
the	NULL
cells	NULL
for	NULL
6	NULL
to	NULL
8	NULL
h.	NULL
B-Galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
4-meth-ylumbelliferyl-B-D-galactosidase	NULL
(	NULL
MUG	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
then	NULL
harvested	NULL
and	NULL
centrifuged	NULL
(	NULL
10	NULL
min	NULL
,	NULL
1,200	NULL
rpm	NULL
,	NULL
4°C	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
1	NULL
ml	NULL
ice	NULL
cold	NULL
Tris-buffered	NULL
saline	NULL
and	NULL
spun	NULL
15	NULL
s	NULL
,	NULL
14,000	NULL
rpm	NULL
,	NULL
4°C	NULL
,	NULL
in	NULL
an	NULL
Eppendorf	NULL
centrifuge	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
0.4	NULL
ml	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
)	NULL
,	NULL
supplemented	NULL
with	NULL
the	NULL
pro-tease	NULL
inhibitors	NULL
Antipain	NULL
(	NULL
1	NULL
mg/ml	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
and	NULL
Leu-peptin	NULL
(	NULL
0.3	NULL
mg/ml	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

25	NULL
pl	NULL
of	NULL
a	NULL
10	NULL
%	NULL
NP-40	NULL
solution	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
was	NULL
added	NULL
and	NULL
cells	NULL
were	NULL
vigorously	NULL
vortexed	NULL
for	NULL
15	NULL
s	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
(	NULL
30	NULL
s	NULL
,	NULL
14,000	NULL
rpm	NULL
)	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
pl	NULL
buffer	NULL
C	NULL
(	NULL
50	NULL
mM	NULL
A	NULL
.	NULL

Sort	NULL
Total	NULL
PBMC	NULL
Lymphocytes	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
%	NULL
vol/vol	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
gentle	NULL
mixing	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
tubes	NULL
were	NULL
spun	NULL
for	NULL
5	NULL
min	NULL
at	NULL
14,000	NULL
rpm	NULL
,	NULL
after	NULL
which	NULL
the	NULL
supernatant	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
was	NULL
transferred	NULL
to	NULL
another	NULL
tube	NULL
.	NULL

Protein	NULL
samples	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Mobility	NULL
shift	NULL
(	NULL
gel	NULL
retardation	NULL
)	NULL
assays	NULL
were	NULL
done	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
protein	NULL
.	NULL

Oligonucle-otides	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
are	NULL
P-labeled	NULL
monomers	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
nuclear	NULL
factor-kB	NULL
(	NULL
NF-kB	NULL
)	NULL
(	NULL
a	NULL
mixture	NULL
of	NULL
complementary	NULL
oli-gonucleotides	NULL
with	NULL
four	NULL
base	NULL
5'-overhangs	NULL
,	NULL
TCGAGTCAGAGGG-GACTTTCCGAG	NULL
and	NULL
CGACTCGGAAAGTCCCCTCTGAC	NULL
)	NULL
or	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
(	NULL
TCGAGTGACTCAGCGCG	NULL
and	NULL
TCG-ACGCGCTGAGTCAC	NULL
)	NULL
.	NULL

Results	NULL
HIV	NULL
infection	NULL
of	NULL
purified	NULL
CD4	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

Subsets	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
healthy	NULL
adult	NULL
donors	NULL
were	NULL
sorted	NULL
to	NULL
>	NULL
98	NULL
%	NULL
purity	NULL
by	NULL
FACS®	NULL
sorting	NULL
(	NULL
>	NULL
99	NULL
%	NULL
expressed	NULL
CD4	NULL
)	NULL
.	NULL

These	NULL
subsets	NULL
were	NULL
identified	NULL
by	NULL
the	NULL
FACS®	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
five	NULL
different	NULL
parameters	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
:	NULL
forward	NULL
and	NULL
side-scattered	NULL
light	NULL
(	NULL
identify-ing	NULL
lymphocytes	NULL
)	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
,	NULL
CD45RA	NULL
,	NULL
and	NULL
CD62L	NULL
.	NULL

This	NULL
combination	NULL
of	NULL
markers	NULL
is	NULL
necessary	NULL
to	NULL
uniquely	NULL
identify	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
1-3	NULL
)	NULL
:	NULL
in	NULL
healthy	NULL
donors	NULL
,	NULL
there	NULL
is	NULL
a	NULL
variable	NULL
representation	NULL
(	NULL
average	NULL
5	NULL
%	NULL
)	NULL
of	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
CD4SRA	NULL
(	NULL
and	NULL
not	NULL
CD4SRO	NULL
)	NULL
but	NULL
do	NULL
not	NULL
express	NULL
Figure	NULL
1	NULL
.	NULL

FACS®	NULL
analysis	NULL
and	NULL
sort	NULL
Forward	NULL
Scatter	NULL
2	NULL
1	NULL
Cell	NULL
Number	NULL
1	NULL
_	NULL
CD4	NULL
T	NULL
cells	NULL
ing	NULL
of	NULL
CD4	NULL
subpopulations	NULL
.	NULL

(	NULL
A	NULL
)	NULL
For	NULL
7	NULL
sorting	NULL
of	NULL
CD4	NULL
subsets	NULL
,	NULL
total	NULL
PBMC	NULL
were	NULL
stained	NULL
for	NULL
expression	NULL
of	NULL
CD62L	NULL
,	NULL
CD45RA	NULL
,	NULL
and	NULL
CD4	NULL
.	NULL

Sorting	NULL
gates	NULL
are	NULL
shown	NULL
,	NULL
(	NULL
eff	NULL
)	NULL
lympho-cytes	NULL
,	NULL
(	NULL
middle	NULL
)	NULL
CD4-positive	NULL
T	NULL
cells	NULL
,	NULL
(	NULL
right	NULL
)	NULL
naive	NULL
,	NULL
memory	NULL
M1	NULL
,	NULL
and	NULL
memory	NULL
M2	NULL
cells	NULL
.	NULL

Cell	NULL
purities	NULL
were	NULL
CD45RA	NULL
0	NULL
mT	NULL
mT	NULL
~T	NULL
m	NULL
100	NULL
Side	NULL
Scatter	NULL
|	NULL
:	NULL
[	NULL
«	NULL
--	NULL
»	NULL
|	NULL
J	NULL
``	NULL
“	NULL
’	NULL
J	NULL
A	NULL
|	NULL
__	NULL
&	NULL
‘	NULL
ﬂﬂ	NULL
10	NULL
_	NULL
100	NULL
CD4	NULL
Naive	NULL
sort	NULL
B.	NULL
Reanalysis	NULL
M1	NULL
sort	NULL
always	NULL
assessed	NULL
immediately	NULL
after	NULL
sorting	NULL
and	NULL
were	NULL
always	NULL
>	NULL
98	NULL
%	NULL
.	NULL

(	NULL
B	NULL
)	NULL
After	NULL
36	NULL
h	NULL
of	NULL
culture	NULL
without	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
restained	NULL
.	NULL

The	NULL
graphs	NULL
are	NULL
shown	NULL
``	NULL
ungated	NULL
;	NULL
``	NULL
i.e	NULL
.	NULL

,	NULL
all	NULL
M2	NULL
sort	NULL
after	NULL
36h	NULL
Before	NULL
infection	NULL
or	NULL
stimulation	NULL
mi	NULL
=	NULL
o	NULL
I	NULL
CD45RA	NULL
a	NULL
m	NULL
I	NULL
events	NULL
are	NULL
displayed	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
uniformly	NULL
CD4	NULL
positive	NULL
and	NULL
retained	NULL
the	NULL
sorting	NULL
phenotype	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
the	NULL
M1	NULL
cells	NULL
are	NULL
expressing	NULL
low	NULL
levels	NULL
of	NULL
CD62L	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
either	NULL
to	NULL
an	NULL
upregulation	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
or	NULL
more	NULL
likely	NULL
to	NULL
inade-	NULL
quate	NULL
resolution	NULL
of	NULL
the	NULL
two	NULL
populations	NULL
at	NULL
the	NULL
time	NULL
of	NULL
sorting	NULL
(	NULL
note	NULL
in	NULL
the	NULL
top	NULL
right	NULL
panel	NULL
of	NULL
A	NULL
that	NULL
there	NULL
is	NULL
100	NULL
7	NULL
C.	NULL
Reanalysis	NULL
after	NULL
6d	NULL
HIV-infected	NULL
,	NULL
CD3/CD28	NULL
stimulated	NULL
|	NULL
Tcell	NULL
|	NULL
blasts	NULL
50	NULL
Forward	NULL
Scatter	NULL
a	NULL
continuum	NULL
of	NULL
expression	NULL
of	NULL
CD62L	NULL
between	NULL
the	NULL
M1	NULL
and	NULL
M2	NULL
populations	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cells	NULL
were	NULL
analyzed	NULL
after	NULL
another	NULL
6	NULL
d	NULL
of	NULL
culture	NULL
.	NULL

Here	NULL
,	NULL
cells	NULL
are	NULL
stained	NULL
with	NULL
antibodies	NULL
as	NULL
well	NULL
as	NULL
Hoechst	NULL
33342	NULL
,	NULL
which	NULL
reveals	NULL
apoptotic	NULL
cells	NULL
(	NULL
see	NULL
also	NULL
Ta	NULL
o	NULL
--	NULL
--	NULL
-0	NULL
100	NULL
200	NULL
300	NULL
I	NULL
``	NULL
I	NULL
T	NULL
TOT	NULL
T	NULL
I	NULL
0	NULL
100	NULL
200	NULL
300	NULL
_	NULL
0	NULL
Hoechst	NULL
33342	NULL
ble	NULL
I	NULL
)	NULL
.	NULL

As	NULL
an	NULL
example	NULL
,	NULL
analyses	NULL
of	NULL
cells	NULL
from	NULL
the	NULL
naive	NULL
,	NULL
M1	NULL
,	NULL
and	NULL
M2	NULL
sorts	NULL
that	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
and	NULL
stimulated	NULL
through	NULL
the	NULL
CD3/	NULL
T	NULL
T	NULL
100	NULL
200	NULL
300	NULL
CD28	NULL
pathways	NULL
are	NULL
shown	NULL
.	NULL

``	NULL
Blasting	NULL
``	NULL
of	NULL
the	NULL
cells	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
significant	NULL
increase	NULL
in	NULL
size	NULL
(	NULL
forward	NULL
scatter	NULL
)	NULL
;	NULL
the	NULL
small	NULL
(	NULL
low	NULL
forward	NULL
scatter	NULL
)	NULL
brightly	NULL
Hoechst-staining	NULL
cells	NULL
are	NULL
apoptotic	NULL
(	NULL
numbers	NULL
over	NULL
the	NULL
arrows	NULL
indicate	NULL
percentage	NULL
of	NULL
these	NULL
apoptotic	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
)	NULL
.	NULL

Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Suppress	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
1557	NULL
A	NULL
.	NULL

B.	NULL
PBMC	NULL
CDsyicpas	NULL
|	NULL
___	NULL
°	NULL
PBMC	NULL
PHA	NULL
Medium	NULL
M2	NULL
CD3/CD28	NULL
M2	NULL
PHA	NULL
Mi	NULL
B	NULL
tnr+rma	NULL
Medium	NULL
C	NULL
]	NULL
Medium	NULL
cwcmsFL—f	NULL
:	NULL
.	NULL

Mi	NULL
PHA	NULL
F	NULL
.	NULL

.	NULL

mi	NULL
|	NULL
O	NULL
TNF	NULL
Naive	NULL
Med	NULL
B	NULL
CD3/CD283+	NULL
TNF	NULL
CD3/CD28	NULL
Id	NULL
-	NULL
Con-A	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
Naive	NULL
PHA	NULL
gig/CD28	NULL
Medium	NULL
+	NULL
p24	NULL
,	NULL
ng/ml	NULL
Naive	NULL
A	NULL
C	NULL
-	NULL
Medium	NULL
0	NULL
0.5	NULL
10	NULL
150	NULL
20	NULL
2.5	NULL
p24	NULL
,	NULL
ng/ml	NULL
ro-0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
1.0	NULL
1.2	NULL
D	NULL
p24	NULL
,	NULL
ng/ml	NULL
®	NULL
357	NULL
E	NULL
U	NULL
37	NULL
2.5	NULL
{	NULL
1	NULL
_	NULL
,	NULL
4	NULL
0.8	NULL
8	NULL
2	NULL
``	NULL
th	NULL
4	NULL
ir	NULL
:	NULL
a	NULL
I	NULL
§	NULL
06	NULL
go	NULL
153	NULL
``	NULL
Tb	NULL
al	NULL
h	NULL
sl	NULL
al	NULL
h	NULL
<	NULL
>	NULL
0.4	NULL
14	NULL
s	NULL
7	NULL
S	NULL
4	NULL
0.2	NULL
0.5	NULL
1	NULL
0	NULL
o	NULL
1	NULL
0	NULL
33	NULL
50	NULL
67	NULL
100	NULL
2	NULL
ll	NULL
)	NULL
Percent	NULL
Memory	NULL
Cells	NULL
Days	NULL
after	NULL
infection	NULL
Figure	NULL
2	NULL
.	NULL

HIV	NULL
does	NULL
not	NULL
replicate	NULL
in	NULL
CD3/CD28-stimulated	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CD4	NULL
subsets	NULL
were	NULL
sorted	NULL
to	NULL
purity	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
infected	NULL
with	NULL
HIV	NULL
,	NULL
and	NULL
left	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
TNFa	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
2	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
3	NULL
d	NULL
,	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
soluble	NULL
p24	NULL
.	NULL

p24	NULL
production	NULL
was	NULL
low	NULL
in	NULL
these	NULL
cultures	NULL
,	NULL
but	NULL
was	NULL
significantly	NULL
increased	NULL
by	NULL
TNFa	NULL
and	NULL
PMA	NULL
stimulation	NULL
in	NULL
PBMC	NULL
and	NULL
purified	NULL
memory	NULL
cells	NULL
;	NULL
p24	NULL
in	NULL
the	NULL
naive	NULL
supernatants	NULL
was	NULL
not	NULL
above	NULL
background	NULL
(	NULL
as	NULL
determined	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
by	NULL
the	NULL
infection	NULL
of	NULL
sort-purified	NULL
CD8	NULL
T	NULL
cells	NULL
with	NULL
HIV	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
detected	NULL
in	NULL
these	NULL
cultures	NULL
is	NULL
well	NULL
correlated	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
infectious	NULL
virus	NULL
present	NULL
in	NULL
the	NULL
supernatant	NULL
(	NULL
30	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
this	NULL
experiment	NULL
,	NULL
we	NULL
infected	NULL
sort-purified	NULL
cells	NULL
with	NULL
HIV	NULL
and	NULL
stimulated	NULL
with	NULL
either	NULL
PHA	NULL
(	NULL
2	NULL
g/ml	NULL
)	NULL
,	NULL
CD3/CD28	NULL
,	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

PHA	NULL
stimulated	NULL
high	NULL
p24	NULL
production	NULL
in	NULL
all	NULL
CD4	NULL
subsets	NULL
and	NULL
total	NULL
PBMC	NULL
;	NULL
however	NULL
,	NULL
costimulation	NULL
of	NULL
the	NULL
CD3/CD28	NULL
pathways	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
p24	NULL
from	NULL
naive	NULL
T	NULL
cells	NULL
above	NULL
background	NULL
.	NULL

For	NULL
each	NULL
cell	NULL
type	NULL
,	NULL
cells	NULL
were	NULL
infected	NULL
before	NULL
separation	NULL
into	NULL
different	NULL
wells	NULL
and	NULL
stimulation	NULL
conditions	NULL
.	NULL

(	NULL
C	NULL
)	NULL
CD4	NULL
subsets	NULL
or	NULL
total	NULL
PBMC	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
and	NULL
stimulated	NULL
under	NULL
the	NULL
conditions	NULL
shown	NULL
.	NULL

p24	NULL
was	NULL
assayed	NULL
after	NULL
5	NULL
d.	NULL
Only	NULL
PHA	NULL
was	NULL
capable	NULL
of	NULL
stimulating	NULL
the	NULL
production	NULL
of	NULL
p24	NULL
in	NULL
infected	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
ConA	NULL
was	NULL
used	NULL
at	NULL
10	NULL
g/ml	NULL
)	NULL
.	NULL

TNFa	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
rescue	NULL
the	NULL
p24	NULL
production	NULL
from	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
kinetics	NULL
of	NULL
p24	NULL
production	NULL
over	NULL
9	NULL
d	NULL
is	NULL
shown	NULL
for	NULL
PHA-	NULL
or	NULL
CD3/	NULL
CD28-stimulated	NULL
cells	NULL
.	NULL

After	NULL
9	NULL
d	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
p24	NULL
in	NULL
the	NULL
naive	NULL
cultures	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
is	NULL
low	NULL
but	NULL
significantly	NULL
above	NULL
background	NULL
.	NULL

(	NULL
£	NULL
)	NULL
Naive	NULL
and	NULL
memory	NULL
M1	NULL
T	NULL
cells	NULL
were	NULL
sorted	NULL
and	NULL
then	NULL
remixed	NULL
in	NULL
different	NULL
percentages	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
HIV	NULL
and	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
.	NULL

The	NULL
p24	NULL
production	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
of	NULL
the	NULL
memory	NULL
phenotype	NULL
,	NULL
suggesting	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
produce	NULL
an	NULL
inhibitory	NULL
factor	NULL
,	NULL
and	NULL
that	NULL
memory	NULL
cells	NULL
can	NULL
not	NULL
``	NULL
rescue	NULL
``	NULL
the	NULL
HIV	NULL
replication	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
memory	NULL
M2	NULL
cells	NULL
or	NULL
with	NULL
total	NULL
memory	NULL
(	NULL
M1	NULL
+	NULL
M2	NULL
)	NULL
cells	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
eight	NULL
independent	NULL
experiments	NULL
on	NULL
cells	NULL
from	NULL
10	NULL
donors	NULL
are	NULL
shown	NULL
.	NULL

CD62L	NULL
(	NULL
reference	NULL
7	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Reanalysis	NULL
of	NULL
sorted	NULL
CD4	NULL
subpopulations	NULL
was	NULL
performed	NULL
immediately	NULL
after	NULL
the	NULL
sort	NULL
to	NULL
verify	NULL
that	NULL
the	NULL
purity	NULL
was	NULL
in	NULL
excess	NULL
of	NULL
98	NULL
%	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
cultured	NULL
for	NULL
24-36	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
.	NULL

The	NULL
methods	NULL
we	NULL
use	NULL
for	NULL
staining	NULL
cells	NULL
with	NULL
fluorescently	NULL
conjugated	NULL
antibodies	NULL
and	NULL
the	NULL
subsequent	NULL
sorting	NULL
are	NULL
done	NULL
in	NULL
such	NULL
a	NULL
way	NULL
that	NULL
the	NULL
functional	NULL
capacity	NULL
of	NULL
these	NULL
cells	NULL
is	NULL
unaltered	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
the	NULL
sorted	NULL
populations	NULL
was	NULL
essentially	NULL
unaltered	NULL
after	NULL
this	NULL
culture	NULL
phase	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

1558	NULL
-	NULL
Roederer	NULL
etal	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
or	NULL
bulk	NULL
PBMC	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
HIV	NULL
derived	NULL
from	NULL
the	NULL
chronically	NULL
infected	NULL
cell	NULL
line	NULL
ACH-2	NULL
,	NULL
the	NULL
LAI	NULL
strain	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HIV	NULL
for	NULL
2	NULL
h	NULL
and	NULL
washed	NULL
extensively	NULL
.	NULL

After	NULL
the	NULL
infection	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
parallel	NULL
cultures	NULL
and	NULL
stimulated	NULL
under	NULL
different	NULL
conditions	NULL
;	NULL
thus	NULL
,	NULL
in	NULL
any	NULL
particular	NULL
experiment	NULL
,	NULL
all	NULL
cells	NULL
of	NULL
a	NULL
particular	NULL
phenotype	NULL
have	NULL
been	NULL
identically	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL

We	NULL
then	NULL
stimulated	NULL
the	NULL
infected	NULL
cells	NULL
with	NULL
PHA	NULL
,	NULL
a	NULL
lectin	NULL
that	NULL
has	NULL
been	NULL
routinely	NULL
used	NULL
to	NULL
generate	NULL
productive	NULL
HIV	NULL
infection	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

PHA	NULL
stimulated	NULL
significant	NULL
HIV	NULL
replica	NULL
tion	NULL
in	NULL
all	NULL
purified	NULL
CD4	NULL
subsets	NULL
,	NULL
as	NULL
well	NULL
as	NULL
bulk	NULL
PBMC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
produced	NULL
as	NULL
much	NULL
HIV	NULL
on	NULL
a	NULL
per-cell	NULL
basis	NULL
as	NULL
did	NULL
memory	NULL
cells	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
infection	NULL
was	NULL
successful	NULL
in	NULL
all	NULL
subsets	NULL
.	NULL

CD3/CD28-stimulated	NULL
naive	NULL
T	NULL
cells	NULL
suppress	NULL
productive	NULL
HIV	NULL
infection	NULL
.	NULL

We	NULL
also	NULL
stimulated	NULL
cells	NULL
through	NULL
the	NULL
CD3/	NULL
CD28	NULL
pathways	NULL
using	NULL
the	NULL
cell	NULL
line	NULL
P815/B7	NULL
(	NULL
9	NULL
)	NULL
.	NULL

This	NULL
murine	NULL
mastocytoma	NULL
is	NULL
transfected	NULL
to	NULL
express	NULL
the	NULL
ligand	NULL
for	NULL
CD28	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
it	NULL
expresses	NULL
murine	NULL
Fc	NULL
receptors	NULL
that	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
and	NULL
cross-linking	NULL
soluble	NULL
antibody	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
Leu4	NULL
,	NULL
which	NULL
is	NULL
anti-CD3	NULL
)	NULL
.	NULL

This	NULL
method	NULL
provides	NULL
a	NULL
substantially	NULL
physiological	NULL
approach	NULL
to	NULL
cross-linking	NULL
the	NULL
CD3	NULL
and	NULL
CD28	NULL
molecules	NULL
.	NULL

Nearly	NULL
100	NULL
%	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
in	NULL
healthy	NULL
adults	NULL
express	NULL
CD28	NULL
.	NULL

Surprisingly	NULL
,	NULL
although	NULL
CD3/CD28	NULL
stimulation	NULL
led	NULL
to	NULL
significantly	NULL
increased	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
preinfected	NULL
PBMC	NULL
and	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
produced	NULL
no	NULL
detectable	NULL
virus	NULL
.	NULL

The	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
clearly	NULL
infected	NULL
with	NULL
HIV	NULL
,	NULL
since	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
,	NULL
parallel	NULL
cultures	NULL
of	NULL
naive	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
produced	NULL
significant	NULL
virus	NULL
.	NULL

(	NULL
Note	NULL
that	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
purified	NULL
subsets	NULL
were	NULL
infected	NULL
before	NULL
separation	NULL
into	NULL
different	NULL
culture	NULL
conditions	NULL
.	NULL
)	NULL

Thus	NULL
,	NULL
stimulation	NULL
by	NULL
cross-linking	NULL
CD3	NULL
and	NULL
CD28	NULL
,	NULL
which	NULL
is	NULL
a	NULL
powerful	NULL
mitogenic	NULL
stimulation	NULL
for	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
reference	NULL
8	NULL
;	NULL
see	NULL
below	NULL
)	NULL
,	NULL
suppressed	NULL
productive	NULL
HIV	NULL
replication	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

TNFa	NULL
and	NULL
PMA	NULL
are	NULL
powerful	NULL
stimulants	NULL
of	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
HIV	NULL
replication	NULL
in	NULL
PHA-blasted	NULL
PBMC	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TNFa	NULL
and	NULL
PMA	NULL
stimulation	NULL
,	NULL
which	NULL
is	NULL
not	NULL
mitogenic	NULL
,	NULL
leads	NULL
to	NULL
a	NULL
significant	NULL
augmentation	NULL
of	NULL
the	NULL
low	NULL
but	NULL
clearly	NULL
detectable	NULL
HIV	NULL
replication	NULL
in	NULL
bulk	NULL
PBMC	NULL
and	NULL
purified	NULL
memory	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
produced	NULL
no	NULL
detectable	NULL
virus	NULL
when	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
TNFa	NULL
and	NULL
PMA	NULL
(	NULL
p24	NULL
levels	NULL
in	NULL
these	NULL
cultures	NULL
were	NULL
not	NULL
above	NULL
background	NULL
levels	NULL
obtained	NULL
by	NULL
HIV	NULL
``	NULL
infection	NULL
``	NULL
of	NULL
purified	NULL
CD8	NULL
T	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
enhancement	NULL
by	NULL
TNFa	NULL
and	NULL
PMA	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
of	NULL
HIV	NULL
to	NULL
infect	NULL
the	NULL
naive	NULL
T	NULL
cells	NULL
nor	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
activate	NULL
the	NULL
necessary	NULL
nuclear	NULL
transcription	NULL
factors	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
TNFa	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
HIV	NULL
LTR-directed	NULL
transcription	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
20	NULL
)	NULL
did	NULL
not	NULL
``	NULL
rescue	NULL
``	NULL
viral	NULL
production	NULL
in	NULL
the	NULL
CD3/CD28-stimulated	NULL
naive	NULL
T	NULL
cells	NULL
TNFa	NULL
did	NULL
potentiate	NULL
CD3/CD28-stimulated	NULL
HIV	NULL
replication	NULL
mildly	NULL
in	NULL
PBMC	NULL
and	NULL
memory	NULL
cells	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
viral	NULL
production	NULL
after	NULL
infection	NULL
of	NULL
the	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
many	NULL
previous	NULL
publications	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Little	NULL
or	NULL
no	NULL
virus	NULL
is	NULL
detectable	NULL
in	NULL
purified	NULL
T	NULL
cell	NULL
cultures	NULL
until	NULL
after	NULL
2	NULL
d	NULL
postinfection	NULL
.	NULL

Viral	NULL
production	NULL
increases	NULL
over	NULL
time	NULL
after	NULL
this	NULL
.	NULL

Interestingly	NULL
,	NULL
9	NULL
d	NULL
after	NULL
CD3/CD28	NULL
stimulation	NULL
,	NULL
there	NULL
is	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
HIV	NULL
detectable	NULL
in	NULL
the	NULL
naive	NULL
cultures	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
HIV	NULL
production	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
persists	NULL
for	NULL
almost	NULL
a	NULL
week-a	NULL
time	NULL
frame	NULL
consistent	NULL
with	NULL
the	NULL
time	NULL
required	NULL
for	NULL
differentiation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
memory	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Purified	NULL
T	NULL
cell	NULL
subsets	NULL
do	NULL
not	NULL
cross-regulate	NULL
HIV	NULL
replication	NULL
.	NULL

We	NULL
performed	NULL
mixing	NULL
experiments	NULL
to	NULL
ask	NULL
whether	NULL
the	NULL
differential	NULL
replication	NULL
in	NULL
CD4	NULL
subsets	NULL
could	NULL
be	NULL
ascribed	NULL
to	NULL
a	NULL
soluble	NULL
factor	NULL
.	NULL

Naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
were	NULL
sorted	NULL
to	NULL
purity	NULL
and	NULL
then	NULL
remixed	NULL
at	NULL
various	NULL
ratios	NULL
.	NULL

These	NULL
artificially	NULL
generated	NULL
mixtures	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
£	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
virus	NULL
production	NULL
from	NULL
these	NULL
mixtures	NULL
is	NULL
closely	NULL
proportional	NULL
to	NULL
the	NULL
fraction	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
cultures	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
major	NULL
source	NULL
of	NULL
virus	NULL
in	NULL
infections	NULL
of	NULL
mixed	NULL
cultures	NULL
is	NULL
the	NULL
memory	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
excludes	NULL
the	NULL
Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Suppress	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
A	NULL
.	NULL

B.	NULL
Donor	NULL
-	NULL
Cells	NULL
1.20	NULL
#	NULL
1	NULL
Memory	NULL
.o	NULL
1.10	NULL
'	NULL
3	NULL
3	NULL
E	NULL
0	NULL
0.5	NULL
1.0	NULL
*	NULL
1.00	NULL
CXCR-4	NULL
/	NULL
B-act	NULL
9	NULL
i	NULL
E	NULL
Naive	NULL
wi	NULL
0.90	NULL
$	NULL
SDF-1	NULL
0.80	NULL
r	NULL
r	NULL
0	NULL
40	NULL
80	NULL
120	NULL
.0	NULL
0.4	NULL
0.8	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
CCR-5	NULL
/	NULL
B-act	NULL
Stimulation	NULL
Cells	NULL
Naive	NULL
PHA	NULL
DNA	NULL
CD3+CD28	NULL
ZJRNA	NULL
Memory	NULL
0	NULL
50	NULL
100	NULL
Relative	NULL
number	NULL
of	NULL
viral	NULL
sequences	NULL
Figure	NULL
3	NULL
.	NULL

Similar	NULL
infectivity	NULL
of	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
coreceptor	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Naive	NULL
and	NULL
total	NULL
memory	NULL
(	NULL
M1	NULL
+	NULL
M2	NULL
)	NULL
cells	NULL
were	NULL
sorted	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

Semiquantitative	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
CXCR-4	NULL
,	NULL
CCR-5	NULL
,	NULL
and	NULL
B-actin	NULL
mRNAs	NULL
was	NULL
performed	NULL
on	NULL
aliquots	NULL
of	NULL
each	NULL
reverse	NULL
transcrip-tion	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
PCR	NULL
product	NULL
was	NULL
quantitated	NULL
;	NULL
the	NULL
expression	NULL
of	NULL
CXCR-4	NULL
and	NULL
CCR-5	NULL
messages	NULL
is	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
B-actin	NULL
expression	NULL
(	NULL
there	NULL
was	NULL
less	NULL
than	NULL
twofold	NULL
variation	NULL
in	NULL
B-actin	NULL
mRNA	NULL
between	NULL
samples	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sorted	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
purified	NULL
SDF-1	NULL
,	NULL
the	NULL
ligand	NULL
for	NULL
CXCR-4	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
calcium	NULL
concentration	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
function	NULL
of	NULL
time	NULL
.	NULL

SDF-1	NULL
was	NULL
added	NULL
at	NULL
10	NULL
s	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
250	NULL
pM	NULL
(	NULL
arrow	NULL
)	NULL
.	NULL

Quantitative	NULL
differences	NULL
in	NULL
calcium	NULL
mobilization	NULL
may	NULL
reflect	NULL
differential	NULL
signal	NULL
transduction	NULL
mechanisms	NULL
,	NULL
similar	NULL
to	NULL
differences	NULL
observed	NULL
for	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
upon	NULL
CD3	NULL
receptor	NULL
engagement	NULL
(	NULL
19	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Sorted	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
were	NULL
infected	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

After	NULL
20	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
viral	NULL
DNA	NULL
,	NULL
or	NULL
viral	NULL
DNA+RNA	NULL
sequences	NULL
using	NULL
quantitative	NULL
PCR	NULL
(	NULL
14	NULL
)	NULL
to	NULL
assess	NULL
the	NULL
amount	NULL
of	NULL
viral	NULL
penetration	NULL
into	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
relative	NULL
amount	NULL
of	NULL
viral	NULL
sequence	NULL
is	NULL
shown	NULL
for	NULL
the	NULL
different	NULL
culture	NULL
stimulations	NULL
.	NULL

A	NULL
second	NULL
experiment	NULL
on	NULL
cells	NULL
from	NULL
a	NULL
different	NULL
donor	NULL
is	NULL
shown	NULL
for	NULL
some	NULL
stimulations	NULL
.	NULL

Detection	NULL
of	NULL
viral	NULL
DNA	NULL
does	NULL
not	NULL
necessarily	NULL
reflect	NULL
viral	NULL
integration	NULL
,	NULL
but	NULL
quantitates	NULL
the	NULL
extent	NULL
of	NULL
reverse	NULL
transcription	NULL
that	NULL
has	NULL
occurred	NULL
.	NULL

(	NULL
Control	NULL
cultures	NULL
analyzed	NULL
immediately	NULL
after	NULL
exposure	NULL
to	NULL
the	NULL
infectious	NULL
supernatant	NULL
had	NULL
<	NULL
20	NULL
%	NULL
of	NULL
the	NULL
signal	NULL
found	NULL
in	NULL
the	NULL
20-h	NULL
experiment	NULL
.	NULL
)	NULL

possibility	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
produce	NULL
a	NULL
soluble	NULL
factor	NULL
that	NULL
inhibits	NULL
HIV	NULL
replication	NULL
.	NULL

Finally	NULL
,	NULL
data	NULL
from	NULL
the	NULL
mixing	NULL
experiment	NULL
suggests	NULL
that	NULL
memory	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
produce	NULL
a	NULL
factor	NULL
that	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
HIV	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
HIV	NULL
coreceptors	NULL
in	NULL
CD4	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

Differential	NULL
infectivity	NULL
of	NULL
the	NULL
purified	NULL
T	NULL
cells	NULL
could	NULL
account	NULL
for	NULL
some	NULL
differences	NULL
in	NULL
HIV	NULL
production	NULL
.	NULL

While	NULL
naive	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
approximately	NULL
fivefold	NULL
less	NULL
infectable	NULL
than	NULL
mem-	NULL
1559	NULL
ory	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
,	NULL
we	NULL
found	NULL
little	NULL
difference	NULL
in	NULL
the	NULL
production	NULL
of	NULL
HIV	NULL
after	NULL
PHA	NULL
stimulation	NULL
.	NULL

Nonetheless	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
PHA	NULL
mediates	NULL
viral	NULL
fusion	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
viral	NULL
coreceptors	NULL
.	NULL

Recently	NULL
,	NULL
two	NULL
different	NULL
surface	NULL
molecules	NULL
on	NULL
T	NULL
cells	NULL
required	NULL
for	NULL
entry	NULL
of	NULL
HIV	NULL
(	NULL
other	NULL
than	NULL
CD4	NULL
)	NULL
,	NULL
CXCR-4/fusin	NULL
(	NULL
21	NULL
)	NULL
and	NULL
CCR-5	NULL
(	NULL
22-26	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
these	NULL
molecules	NULL
in	NULL
HIV	NULL
infection	NULL
of	NULL
purified	NULL
CD4	NULL
subsets	NULL
,	NULL
we	NULL
quantitated	NULL
expression	NULL
of	NULL
the	NULL
messenger	NULL
RNA	NULL
molecules	NULL
encoding	NULL
these	NULL
gene	NULL
products	NULL
.	NULL

Using	NULL
semiquantitative	NULL
PCR	NULL
,	NULL
we	NULL
found	NULL
that	NULL
both	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
express	NULL
similar	NULL
levels	NULL
of	NULL
mRNA	NULL
for	NULL
these	NULL
two	NULL
coreceptors	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
expression	NULL
,	NULL
preliminary	NULL
studies	NULL
with	NULL
fluorescently	NULL
conjugated	NULL
antibodies	NULL
to	NULL
CXCR-4	NULL
show	NULL
that	NULL
all	NULL
CD4	NULL
T	NULL
cells	NULL
express	NULL
the	NULL
receptor	NULL
on	NULL
the	NULL
surface	NULL
(	NULL
M.	NULL
Roederer	NULL
,	NULL
unpublished	NULL
observations	NULL
;	NULL
N.	NULL
Landau	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
costimulation	NULL
through	NULL
CD3	NULL
and	NULL
CD28	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CXCR-4	NULL
gene	NULL
on	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
C.	NULL
June	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
,	NULL
both	NULL
purified	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
exhibit	NULL
a	NULL
calcium	NULL
flux	NULL
in	NULL
response	NULL
to	NULL
stromal-derived	NULL
factor	NULL
(	NULL
SDF	NULL
)	NULL
-1	NULL
,	NULL
the	NULL
ligand	NULL
for	NULL
CXCR-4	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
subsets	NULL
express	NULL
equivalent	NULL
amounts	NULL
of	NULL
CXCR-4	NULL
and	NULL
CCR-5	NULL
message	NULL
and	NULL
similar	NULL
levels	NULL
of	NULL
CXCR-4	NULL
protein	NULL
,	NULL
and	NULL
both	NULL
subsets	NULL
express	NULL
functional	NULL
CXCR-4	NULL
capable	NULL
of	NULL
transducing	NULL
signal	NULL
.	NULL

Quantitative	NULL
differences	NULL
in	NULL
calcium	NULL
flux	NULL
between	NULL
these	NULL
subsets	NULL
do	NULL
not	NULL
necessarily	NULL
reflect	NULL
similar	NULL
quantitative	NULL
differences	NULL
in	NULL
receptor	NULL
expression	NULL
:	NULL
CD4	NULL
subsets	NULL
show	NULL
differential	NULL
calcium	NULL
flux	NULL
in	NULL
response	NULL
to	NULL
CD3	NULL
triggering	NULL
,	NULL
even	NULL
though	NULL
they	NULL
express	NULL
identical	NULL
amounts	NULL
of	NULL
CD3	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
quantitatively	NULL
different	NULL
surface	NULL
expression	NULL
of	NULL
viral	NULL
coreceptors	NULL
on	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
leads	NULL
to	NULL
differential	NULL
infectivity	NULL
was	NULL
directly	NULL
assessed	NULL
by	NULL
quantitating	NULL
the	NULL
amount	NULL
of	NULL
viral	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
cells	NULL
20	NULL
h	NULL
postinfection	NULL
.	NULL

At	NULL
this	NULL
early	NULL
time	NULL
point	NULL
,	NULL
which	NULL
would	NULL
be	NULL
relatively	NULL
soon	NULL
after	NULL
potential	NULL
proviral	NULL
integration	NULL
,	NULL
there	NULL
should	NULL
be	NULL
little	NULL
effect	NULL
of	NULL
the	NULL
stimulants	NULL
on	NULL
the	NULL
upregulation	NULL
of	NULL
viral	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
quantitating	NULL
the	NULL
viral	NULL
RNA	NULL
(	NULL
or	NULL
viral	NULL
DNA	NULL
)	NULL
levels	NULL
should	NULL
reflect	NULL
primarily	NULL
the	NULL
amount	NULL
of	NULL
virus	NULL
that	NULL
has	NULL
entered	NULL
the	NULL
cell	NULL
(	NULL
al-though	NULL
not	NULL
necessarily	NULL
integrated	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
quantitative	NULL
PCR	NULL
for	NULL
either	NULL
viral	NULL
DNA	NULL
or	NULL
viral	NULL
DNA	NULL
plus	NULL
viral	NULL
RNA	NULL
showed	NULL
substantially	NULL
equivalent	NULL
levels	NULL
of	NULL
infection	NULL
in	NULL
both	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
irrespective	NULL
of	NULL
the	NULL
culture	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

This	NULL
confirms	NULL
that	NULL
stimulation	NULL
by	NULL
PHA	NULL
or	NULL
CD3/CD28	NULL
after	NULL
the	NULL
infection	NULL
of	NULL
the	NULL
cells	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
entry	NULL
of	NULL
HIV	NULL
into	NULL
naive	NULL
or	NULL
memory	NULL
cells	NULL
.	NULL

Differential	NULL
proliferation	NULL
or	NULL
apoptosis	NULL
of	NULL
T	NULL
cell	NULL
subsets	NULL
does	NULL
not	NULL
account	NULL
for	NULL
differential	NULL
HIV	NULL
production	NULL
.	NULL

We	NULL
undertook	NULL
a	NULL
series	NULL
of	NULL
functional	NULL
assays	NULL
on	NULL
the	NULL
purified	NULL
CD4	NULL
subsets	NULL
to	NULL
try	NULL
to	NULL
understand	NULL
mechanisms	NULL
that	NULL
might	NULL
account	NULL
for	NULL
the	NULL
differential	NULL
ability	NULL
of	NULL
naive	NULL
and	NULL
memory	NULL
cells	NULL
to	NULL
support	NULL
productive	NULL
HIV	NULL
replication	NULL
.	NULL

The	NULL
simplest	NULL
assay	NULL
quantitates	NULL
the	NULL
proliferative	NULL
capacity	NULL
on	NULL
a	NULL
per-cell	NULL
basis	NULL
.	NULL

As	NULL
is	NULL
well	NULL
known	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
have	NULL
,	NULL
in	NULL
general	NULL
,	NULL
a	NULL
greater	NULL
proliferative	NULL
capacity	NULL
(	NULL
on	NULL
a	NULL
per-cell	NULL
basis	NULL
)	NULL
than	NULL
do	NULL
their	NULL
memory	NULL
counterparts	NULL
.	NULL

As	NULL
Fig	NULL
.	NULL

4	NULL
shows	NULL
,	NULL
this	NULL
is	NULL
the	NULL
case	NULL
for	NULL
both	NULL
PHA	NULL
stimulation	NULL
as	NULL
well	NULL
as	NULL
CD3/CD28	NULL
stimulation	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
CD3/CD28	NULL
stimulation	NULL
is	NULL
a	NULL
very	NULL
powerful	NULL
mitogenic	NULL
signal	NULL
,	NULL
resulting	NULL
in	NULL
manyfold	NULL
greater	NULL
proliferation	NULL
than	NULL
PHA	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
the	NULL
cultures	NULL
,	NULL
while	NULL
having	NULL
a	NULL
mild	NULL
damping	NULL
of	NULL
the	NULL
proliferative	NULL
capacity	NULL
,	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
relative	NULL
stim-ulations	NULL
by	NULL
PHA	NULL
and	NULL
CD3/CD28	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
best	NULL
proliferation	NULL
observed	NULL
in	NULL
these	NULL
various	NULL
cultures	NULL
was	NULL
for	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
by	NULL
CD3/CD28	NULL
,	NULL
no	NULL
viral	NULL
production	NULL
was	NULL
ob	NULL
1560	NULL
_	NULL
Roederer	NULL
etal	NULL
.	NULL

&	NULL
0	NULL
M2	NULL
gi	NULL
A	NULL
CD3/CD28	NULL
°|	NULL
M	NULL
Unstimulated	NULL
zElh|ﬁ	NULL
*	NULL
HIV-infected	NULL
M1	NULL
e	NULL
°	NULL
no	NULL
HIV	NULL
&	NULL
0	NULL
o—	NULL
0	NULL
--	NULL
-	NULL
Naive	NULL
.	NULL

a	NULL
I	NULL
I	NULL
I	NULL
I	NULL
T	NULL
~-	NULL
4	NULL
t	NULL
10,000	NULL
20,000	NULL
30,000	NULL
3H-Thymidine	NULL
(	NULL
cpm	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
proliferate	NULL
much	NULL
more	NULL
than	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

4	NULL
d	NULL
after	NULL
HIV	NULL
infection	NULL
(	NULL
or	NULL
mock	NULL
infec-tion	NULL
)	NULL
,	NULL
cell	NULL
proliferation	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
incorporation	NULL
of	NULL
°H-thy-midine	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
CD3/CD28	NULL
stimulation	NULL
provides	NULL
a	NULL
much	NULL
stronger	NULL
proliferative	NULL
signal	NULL
than	NULL
does	NULL
PHA	NULL
.	NULL

Infection	NULL
with	NULL
HIV	NULL
consistently	NULL
resulted	NULL
in	NULL
a	NULL
slight	NULL
decrease	NULL
in	NULL
proliferation	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
(	NULL
but	NULL
no	NULL
statistically	NULL
significant	NULL
change	NULL
in	NULL
apoptosis	NULL
)	NULL
.	NULL

This	NULL
is	NULL
one	NULL
of	NULL
two	NULL
experiments	NULL
testing	NULL
proliferation	NULL
on	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Results	NULL
from	NULL
mock-infected	NULL
cells	NULL
are	NULL
consistent	NULL
with	NULL
many	NULL
independent	NULL
experi-ments	NULL
.	NULL

served	NULL
in	NULL
those	NULL
cultures	NULL
(	NULL
some	NULL
of	NULL
the	NULL
experiments	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
;	NULL
all	NULL
proliferation	NULL
experiments	NULL
included	NULL
p24	NULL
measurements	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
breaks	NULL
the	NULL
previously	NULL
accepted	NULL
link	NULL
between	NULL
cellular	NULL
and	NULL
viral	NULL
proliferation	NULL
,	NULL
and	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
other	NULL
aspects	NULL
of	NULL
cellular	NULL
activation	NULL
are	NULL
necessary	NULL
for	NULL
HIV	NULL
replication	NULL
;	NULL
i.e	NULL
.	NULL

,	NULL
not	NULL
necessarily	NULL
ones	NULL
that	NULL
lead	NULL
to	NULL
proliferation	NULL
.	NULL

Kobayashi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
demonstrated	NULL
an	NULL
increase	NULL
of	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
assessed	NULL
apoptosis	NULL
6	NULL
d	NULL
after	NULL
HIV	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
for	NULL
all	NULL
culture	NULL
conditions	NULL
(	NULL
PHA	NULL
,	NULL
CD3/CD28	NULL
,	NULL
and	NULL
with	NULL
or	NULL
without	NULL
HIV	NULL
infection	NULL
)	NULL
.	NULL

While	NULL
the	NULL
extent	NULL
of	NULL
apoptosis	NULL
depended	NULL
on	NULL
the	NULL
stimulation	NULL
condition	NULL
and	NULL
cell	NULL
type	NULL
,	NULL
we	NULL
found	NULL
no	NULL
discernible	NULL
trend	NULL
in	NULL
apoptosis	NULL
comparing	NULL
infected	NULL
with	NULL
uninfected	NULL
cultures	NULL
.	NULL

Naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
have	NULL
significantly	NULL
different	NULL
cytokine	NULL
profiles	NULL
.	NULL

In	NULL
general	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
make	NULL
only	NULL
IL-2	NULL
;	NULL
memory	NULL
T	NULL
cells	NULL
can	NULL
make	NULL
the	NULL
entire	NULL
spectrum	NULL
of	NULL
T	NULL
cell	NULL
cytokines	NULL
.	NULL

Using	NULL
competitive	NULL
PCR	NULL
,	NULL
we	NULL
quantitated	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
y-IFN	NULL
by	NULL
the	NULL
CD4	NULL
subsets	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
production	NULL
of	NULL
these	NULL
cytokines	NULL
is	NULL
quantitatively	NULL
identical	NULL
for	NULL
the	NULL
same	NULL
subset	NULL
isolated	NULL
from	NULL
different	NULL
individuals	NULL
.	NULL

Thus	NULL
,	NULL
differences	NULL
in	NULL
cytokine	NULL
profiles	NULL
for	NULL
bulk	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
relative	NULL
representation	NULL
of	NULL
functionally	NULL
distinct	NULL
subsets	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
subsets	NULL
to	NULL
produce	NULL
cytokines	NULL
that	NULL
directly	NULL
stimulate	NULL
HIV	NULL
LTR-directed	NULL
transcription	NULL
,	NULL
we	NULL
used	NULL
a	NULL
reporter	NULL
gene	NULL
system	NULL
(	NULL
15	NULL
)	NULL
in	NULL
cells	NULL
that	NULL
are	NULL
responsive	NULL
primarily	NULL
to	NULL
IL-1	NULL
and	NULL
TNFa	NULL
.	NULL

In	NULL
general	NULL
,	NULL
supernatants	NULL
from	NULL
stimulated	NULL
cultures	NULL
showed	NULL
very	NULL
strong	NULL
stimulatory	NULL
activity	NULL
for	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
cultured	NULL
subsets	NULL
had	NULL
been	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL

However	NULL
,	NULL
supernatants	NULL
from	NULL
naive	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
were	NULL
far	NULL
less	NULL
effective	NULL
than	NULL
were	NULL
supernatants	NULL
from	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
supernatants	NULL
from	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
were	NULL
as	NULL
Table	NULL
I.	NULL
Apoptosis	NULL
in	NULL
Purified	NULL
T	NULL
Cell	NULL
Cultures	NULL
Naive	NULL
M1	NULL
M2	NULL
Stimulation	NULL
No	NULL
HIV	NULL
+HIV	NULL
_	NULL
No	NULL
HIV	NULL
-	NULL
+HIV	NULL
_	NULL
No	NULL
HIV	NULL
+HIV	NULL
Experiment	NULL
1	NULL
None	NULL
42	NULL
55	NULL
14	NULL
13	NULL
6.3	NULL
11	NULL
PHA	NULL
18	NULL
10	NULL
21	NULL
27	NULL
28	NULL
21	NULL
CD3/CD28	NULL
47	NULL
40	NULL
32	NULL
31	NULL
24	NULL
25	NULL
Experiment	NULL
2	NULL
None	NULL
30	NULL
46	NULL
7.8	NULL
12	NULL
16	NULL
9.7	NULL
PHA	NULL
8.7	NULL
10	NULL
25	NULL
13	NULL
25	NULL
23	NULL
CD3/CD28	NULL
26	NULL
25	NULL
29	NULL
27	NULL
31	NULL
27	NULL
Numbers	NULL
represent	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
that	NULL
were	NULL
apoptotic	NULL
using	NULL
the	NULL
Hoechst	NULL
33342	NULL
assay	NULL
by	NULL
FACS®	NULL
.	NULL

Purified	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
or	NULL
mock	NULL
infected	NULL
,	NULL
stimulated	NULL
as	NULL
shown	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
6	NULL
d.	NULL
stimulatory	NULL
as	NULL
those	NULL
from	NULL
memory	NULL
cells	NULL
.	NULL

This	NULL
difference	NULL
parallels	NULL
the	NULL
observed	NULL
difference	NULL
in	NULL
the	NULL
capacity	NULL
of	NULL
HIV	NULL
to	NULL
productively	NULL
replicate	NULL
in	NULL
these	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Supernatants	NULL
from	NULL
memory	NULL
cells	NULL
are	NULL
clearly	NULL
stimulatory	NULL
for	NULL
HIV	NULL
transcription	NULL
and	NULL
presumably	NULL
for	NULL
replication	NULL
.	NULL

However	NULL
,	NULL
these	NULL
soluble	NULL
factors	NULL
did	NULL
not	NULL
restore	NULL
productive	NULL
HIV	NULL
infection	NULL
A	NULL
.	NULL

Competitor	NULL
RNA	NULL
,	NULL
}	NULL
copies	NULL
per	NULL
cell	NULL
Naive	NULL
«	NULL
-	NULL
ab	NULL
an	NULL
an	NULL
Memory	NULL
M2	NULL
itt	NULL
C.	NULL
Supernatant	NULL
from	NULL
PBMC	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
when	NULL
memory	NULL
and	NULL
naive	NULL
T	NULL
cells	NULL
were	NULL
mixed	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
£	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
appear	NULL
to	NULL
lack	NULL
the	NULL
receptors	NULL
to	NULL
transmit	NULL
the	NULL
signals	NULL
from	NULL
the	NULL
soluble	NULL
factors	NULL
.	NULL

Activation	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
is	NULL
normal	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
subsets	NULL
to	NULL
activate	NULL
nuclear	NULL
factors	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
regulatory	NULL
regions	NULL
on	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

The	NULL
most	NULL
important	NULL
of	NULL
these	NULL
is	NULL
NF-kB	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
significantly	NULL
enhance	NULL
HIV	NULL
LTR-directed	NULL
transcription	NULL
and	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
TNFa-mediated	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
20	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
are	NULL
activated	NULL
in	NULL
stimulated	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

While	NULL
not	NULL
unexpected	NULL
,	NULL
this	NULL
finding	NULL
is	NULL
surprising	NULL
in	NULL
view	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
no	NULL
detectable	NULL
HIV	NULL
is	NULL
produced	NULL
by	NULL
the	NULL
stimulated	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
block	NULL
of	NULL
HIV	NULL
production	NULL
within	NULL
these	NULL
cells	NULL
when	NULL
stimulated	NULL
by	NULL
CD3/CD28	NULL
does	NULL
not	NULL
include	NULL
a	NULL
block	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
factors	NULL
important	NULL
to	NULL
HIV	NULL
transcription	NULL
regulation	NULL
.	NULL

Discussion	NULL
The	NULL
data	NULL
we	NULL
present	NULL
demonstrates	NULL
that	NULL
HIV	NULL
replication	NULL
is	NULL
not	NULL
necessarily	NULL
correlated	NULL
with	NULL
cellular	NULL
replication	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
conditions	NULL
that	NULL
resulted	NULL
in	NULL
the	NULL
greatest	NULL
cellular	NULL
replication	NULL
resulted	NULL
in	NULL
undetectable	NULL
viral	NULL
production	NULL
Figure	NULL
5	NULL
.	NULL

CD4	NULL
subsets	NULL
have	NULL
yIFN	NULL
5	NULL
significantly	NULL
different	NULL
cyto-g	NULL
kine	NULL
profiles	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Quantita-	NULL
ummm	NULL
im	NULL
tive	NULL
competitive	NULL
PCR	NULL
(	NULL
13	NULL
)	NULL
=	NULL
was	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
y-IFN	NULL
by	NULL
CD4	NULL
subsets	NULL
.	NULL

mRNA	NULL
was	NULL
isolated	NULL
from	NULL
each	NULL
cell	NULL
type	NULL
after	NULL
stimulation	NULL
for	NULL
8	NULL
h.	NULL
Aliquots	NULL
of	NULL
the	NULL
mRNA	NULL
were	NULL
mixed	NULL
with	NULL
dilutions	NULL
of	NULL
known	NULL
numbers	NULL
of	NULL
RNAs	NULL
identical	NULL
to	NULL
each	NULL
cy-tokine	NULL
,	NULL
but	NULL
with	NULL
an	NULL
internal	NULL
deletion	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
typical	NULL
gel	NULL
for	NULL
naive	NULL
and	NULL
memory	NULL
M2	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantita-	NULL
l	NULL
|	NULL
M2	NULL
tion	NULL
of	NULL
the	NULL
competitive	NULL
PCR	NULL
2-j	NULL
assay	NULL
for	NULL
sorted	NULL
cells	NULL
from	NULL
IL-4	NULL
1	NULL
:	NULL
|	NULL
|	NULL
four	NULL
different	NULL
donors	NULL
;	NULL
aster	NULL
--	NULL
|	NULL
l—l—l	NULL
H	NULL
Unstimulated	NULL
__	NULL
jsks	NULL
indicate	NULL
undetectable	NULL
g-L-*-*	NULL
M1	NULL
mRNA	NULL
production	NULL
.	NULL

Cells	NULL
ya	NULL
?	NULL

Elijjﬁzzjed	NULL
were	NULL
either	NULL
stimulated	NULL
with	NULL
1.07	NULL
o	NULL
No	NULL
HIV	NULL
PHA	NULL
,	NULL
cross-linked	NULL
CD3	NULL
-	NULL
;	NULL
alone	NULL
,	NULL
or	NULL
cross-linked	NULL
CD3	NULL
yIFN	NULL
095-4	NULL
Naive	NULL
and	NULL
CD28	NULL
.	NULL

Error	NULL
bars	NULL
are	NULL
mean*1SD	NULL
.	NULL

There	NULL
is	NULL
a	NULL
re-_L_*	NULL
&	NULL
£	NULL
LL	NULL
*	NULL
2	NULL
.	NULL

T	NULL
F	NULL
T	NULL
1	NULL
-	NULL
A	NULL
N	NULL
Mi	NULL
M2	NULL
N	NULL
Mi	NULL
M2	NULL
]	NULL
N	NULL
Mi	NULL
M2	NULL
0	NULL
40	NULL
so	NULL
120	NULL
160	NULL
markable	NULL
consistency	NULL
in	NULL
the	NULL
PHX	NULL
eps	NULL
Stimulation	NULL
of	NULL
HIV-LTR	NULL
number	NULL
of	NULL
cytokine	NULL
messen-	NULL
|	NULL
ger	NULL
RNA	NULL
molecules	NULL
per	NULL
cell	NULL
(	NULL
ordinate	NULL
)	NULL
for	NULL
purified	NULL
subsets	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Only	NULL
M2	NULL
memory	NULL
cells	NULL
produced	NULL
IL-4	NULL
,	NULL
consistent	NULL
with	NULL
their	NULL
known	NULL
role	NULL
of	NULL
providing	NULL
B	NULL
cell	NULL
help	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Supernatants	NULL
from	NULL
HIV-infected	NULL
(	NULL
or	NULL
mock-infected	NULL
)	NULL
cultures	NULL
of	NULL
sorted	NULL
CD4	NULL
cells	NULL
or	NULL
PBMC	NULL
were	NULL
added	NULL
to	NULL
the	NULL
293.72.2	NULL
cell	NULL
line	NULL
in	NULL
quadruplicate	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
expresses	NULL
B-galactosidase	NULL
under	NULL
control	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

We	NULL
have	NULL
used	NULL
it	NULL
extensively	NULL
to	NULL
assess	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
293.27.2	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
8	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
supernatant	NULL
,	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
293.27.2	NULL
cell	NULL
line	NULL
is	NULL
not	NULL
responsive	NULL
to	NULL
PHA	NULL
or	NULL
anti-CD3	NULL
.	NULL

10	NULL
U	NULL
activity	NULL
represents	NULL
the	NULL
basal	NULL
(	NULL
unstimulated	NULL
)	NULL
expression	NULL
of	NULL
B-galactosidase	NULL
by	NULL
the	NULL
cell	NULL
line	NULL
.	NULL

Replicate	NULL
wells	NULL
had	NULL
an	NULL
average	NULL
variation	NULL
of	NULL
<	NULL
10	NULL
%	NULL
.	NULL

Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Suppress	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
1561	NULL
Probe	NULL
NF-kB	NULL
AP-1	NULL
Cell	NULL
Type	NULL
Naive	NULL
Memory	NULL
Naive	NULL
Memory	NULL
©	NULL
|	NULL
a	NULL
o	NULL
<	NULL
oo	NULL
<	NULL
cn	NULL
<	NULL
5	NULL
8	NULL
|	NULL
&	NULL
A	NULL
|	NULL
&	NULL
A|	NULL
A|	NULL
g	NULL
2	NULL
E	NULL
E	NULL
u	NULL
5:3	NULL
5	NULL
:	NULL
u	NULL
5:5	NULL
$	NULL
3	NULL
.	NULL

u	NULL
U	NULL
&	NULL
Stimulation	NULL
_	NULL
2	NULL
s|	NULL
$	NULL
l	NULL
8|	NULL
%	NULL
S	NULL
z	NULL
|EIO|IELz|ER	NULL
]	NULL
O|ELz|E	NULL
)	NULL
|O|E	NULL
]	NULL
z|E	NULL
]	NULL
|O|	NULL
E	NULL
.	NULL

“	NULL
v	NULL
th	NULL
¥	NULL
w*	NULL
<	NULL
,	NULL
va	NULL
#	NULL
p50	NULL
:	NULL
p65	NULL
-	NULL
»	NULL
.	NULL

#	NULL
--	NULL
-	NULL
fos/jun	NULL
p50	NULL
:	NULL
p50	NULL
-	NULL
#	NULL
.	NULL

be	NULL
'	NULL
Figure	NULL
6	NULL
.	NULL

Naive	NULL
and	NULL
memory	NULL
cells	NULL
show	NULL
similar	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
.	NULL

Sorted	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PHA	NULL
or	NULL
CD3/	NULL
CD28	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
NF-kB	NULL
or	NULL
AP-1	NULL
binding	NULL
activity	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Arrows	NULL
show	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
p50	NULL
:	NULL
p50	NULL
homodimers	NULL
and	NULL
p50	NULL
:	NULL
p65	NULL
Free	NULL
Free	NULL
heterodimers	NULL
(	NULL
NF-KB	NULL
)	NULL
,	NULL
or	NULL
the	NULL
AP-1	NULL
Probe	NULL
Probe	NULL
__	NULL
pinding	NULL
complex	NULL
.	NULL

(	NULL
naive	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
CD3/CD28	NULL
)	NULL
.	NULL

Even	NULL
when	NULL
stimulated	NULL
with	NULL
PHA	NULL
,	NULL
memory	NULL
cells	NULL
,	NULL
which	NULL
had	NULL
significantly	NULL
lower	NULL
proliferative	NULL
responses	NULL
than	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
still	NULL
produced	NULL
as	NULL
much	NULL
or	NULL
more	NULL
virus	NULL
.	NULL

These	NULL
findings	NULL
have	NULL
importance	NULL
for	NULL
the	NULL
interpretation	NULL
of	NULL
data	NULL
from	NULL
viral	NULL
replication	NULL
or	NULL
other	NULL
studies	NULL
with	NULL
cultured	NULL
PBMC	NULL
,	NULL
since	NULL
the	NULL
proportions	NULL
of	NULL
various	NULL
subsets	NULL
in	NULL
these	NULL
cultures	NULL
is	NULL
uncontrolled	NULL
and	NULL
usually	NULL
unknown	NULL
.	NULL

As	NULL
Fig	NULL
.	NULL

2	NULL
E	NULL
shows	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
viral	NULL
replication	NULL
obtained	NULL
from	NULL
a	NULL
mixture	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
primarily	NULL
dependent	NULL
on	NULL
the	NULL
representation	NULL
of	NULL
memory	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
.	NULL

Similarly	NULL
,	NULL
results	NULL
from	NULL
functional	NULL
assays	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
proliferation	NULL
or	NULL
cytokine	NULL
production	NULL
)	NULL
will	NULL
be	NULL
heavily	NULL
influenced	NULL
by	NULL
the	NULL
memory	NULL
cell	NULL
representation	NULL
in	NULL
the	NULL
culture	NULL
,	NULL
since	NULL
memory	NULL
T	NULL
cells	NULL
have	NULL
very	NULL
different	NULL
functional	NULL
capacities	NULL
.	NULL

While	NULL
the	NULL
representation	NULL
of	NULL
naive	NULL
cells	NULL
in	NULL
the	NULL
periphery	NULL
averages	NULL
50	NULL
%	NULL
in	NULL
healthy	NULL
individuals	NULL
(	NULL
7	NULL
)	NULL
,	NULL
there	NULL
is	NULL
still	NULL
considerable	NULL
variation	NULL
.	NULL

Thus	NULL
,	NULL
comparison	NULL
of	NULL
functional	NULL
data	NULL
including	NULL
HIV	NULL
replication	NULL
between	NULL
different	NULL
donors	NULL
must	NULL
be	NULL
done	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
underlying	NULL
composition	NULL
of	NULL
the	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
problem	NULL
is	NULL
even	NULL
greater	NULL
in	NULL
samples	NULL
from	NULL
HIV-infected	NULL
individuals	NULL
.	NULL

These	NULL
individuals	NULL
,	NULL
especially	NULL
in	NULL
late-stage	NULL
disease	NULL
,	NULL
usually	NULL
have	NULL
significantly	NULL
decreased	NULL
representation	NULL
of	NULL
the	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
consequently	NULL
increased	NULL
proportions	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Conclusions	NULL
concerning	NULL
functional	NULL
differences	NULL
in	NULL
PBMC	NULL
between	NULL
HIV-infected	NULL
and	NULL
healthy	NULL
individuals	NULL
should	NULL
be	NULL
evaluated	NULL
with	NULL
these	NULL
changes	NULL
in	NULL
mind	NULL
to	NULL
assess	NULL
the	NULL
impact	NULL
of	NULL
cell	NULL
subset	NULL
representation	NULL
changes	NULL
on	NULL
the	NULL
results	NULL
.	NULL

Indeed	NULL
,	NULL
functional	NULL
changes	NULL
that	NULL
have	NULL
been	NULL
demonstrated	NULL
in	NULL
bulk	NULL
populations	NULL
may	NULL
be	NULL
due	NULL
solely	NULL
to	NULL
subset	NULL
representation	NULL
,	NULL
with	NULL
1562	NULL
-	NULL
Roederer	NULL
etal	NULL
.	NULL

no	NULL
change	NULL
whatsoever	NULL
in	NULL
the	NULL
functional	NULL
capacity	NULL
of	NULL
any	NULL
given	NULL
cell	NULL
type	NULL
.	NULL

Our	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
T	NULL
cell	NULL
tropic	NULL
virus	NULL
(	NULL
LAI	NULL
)	NULL
;	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
or	NULL
not	NULL
similar	NULL
observations	NULL
will	NULL
hold	NULL
true	NULL
for	NULL
monocytotropic	NULL
viruses	NULL
.	NULL

Certainly	NULL
,	NULL
tropism	NULL
may	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
different	NULL
viruses	NULL
to	NULL
enter	NULL
different	NULL
subsets	NULL
,	NULL
even	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Such	NULL
an	NULL
effect	NULL
would	NULL
be	NULL
amplified	NULL
in	NULL
long	NULL
term	NULL
cultures	NULL
,	NULL
where	NULL
multiple	NULL
cycles	NULL
of	NULL
rein-fection	NULL
can	NULL
occur	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
monocytotropic	NULL
viruses	NULL
may	NULL
not	NULL
show	NULL
the	NULL
same	NULL
inhibition	NULL
for	NULL
replication	NULL
once	NULL
they	NULL
have	NULL
entered	NULL
naive	NULL
T	NULL
cells	NULL
as	NULL
does	NULL
LAL	NULL
.	NULL

The	NULL
data	NULL
we	NULL
have	NULL
presented	NULL
here	NULL
extend	NULL
the	NULL
demonstration	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
intrinsically	NULL
resistant	NULL
to	NULL
HIV	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Clearly	NULL
,	NULL
HIV	NULL
is	NULL
capable	NULL
of	NULL
infecting	NULL
these	NULL
cells	NULL
,	NULL
but	NULL
this	NULL
infection	NULL
is	NULL
rendered	NULL
nonproductive	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
stimulated	NULL
with	NULL
the	NULL
physiological	NULL
signals	NULL
provided	NULL
by	NULL
CD3/CD28	NULL
cross-linking	NULL
.	NULL

(	NULL
Importantly	NULL
,	NULL
the	NULL
inhibition	NULL
demonstrated	NULL
in	NULL
our	NULL
experiments	NULL
is	NULL
an	NULL
effect	NULL
on	NULL
virus	NULL
that	NULL
has	NULL
already	NULL
entered	NULL
cells	NULL
.	NULL

Other	NULL
mechanisms	NULL
,	NULL
such	NULL
as	NULL
specific	NULL
downregulation	NULL
of	NULL
coreceptors	NULL
,	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
in	NULL
playing	NULL
a	NULL
role	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
virus	NULL
in	NULL
long	NULL
term	NULL
cultures	NULL
such	NULL
as	NULL
those	NULL
described	NULL
by	NULL
Levine	NULL
et	NULL
al	NULL
.	NULL

;	NULL
reference	NULL
8	NULL
.	NULL
)	NULL

As	NULL
yet	NULL
,	NULL
we	NULL
do	NULL
not	NULL
understand	NULL
the	NULL
basis	NULL
for	NULL
this	NULL
inhibition	NULL
.	NULL

The	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
responding	NULL
strongly	NULL
to	NULL
the	NULL
stimulation	NULL
,	NULL
including	NULL
activating	NULL
the	NULL
nuclear	NULL
factors	NULL
NFB	NULL
and	NULL
AP-1	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
inhibition	NULL
of	NULL
HIV	NULL
occurs	NULL
at	NULL
a	NULL
pre-transcriptional	NULL
stage	NULL
;	NULL
i.e	NULL
.	NULL

,	NULL
steps	NULL
of	NULL
virus	NULL
processing	NULL
after	NULL
infection	NULL
,	NULL
including	NULL
integration	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
mechanisms	NULL
leading	NULL
to	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
is	NULL
responsible	NULL
.	NULL

Certainly	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
make	NULL
most	NULL
cyto-	NULL
kines	NULL
after	NULL
CD3/CD28	NULL
stimulation	NULL
:	NULL
thus	NULL
,	NULL
a	NULL
negative	NULL
regulatory	NULL
mechanism	NULL
exists	NULL
in	NULL
these	NULL
cells	NULL
to	NULL
prevent	NULL
expression	NULL
of	NULL
those	NULL
cytokine	NULL
genes	NULL
.	NULL

Since	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
is	NULL
in	NULL
many	NULL
ways	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
inflammatory	NULL
genes	NULL
,	NULL
it	NULL
is	NULL
quite	NULL
possible	NULL
that	NULL
the	NULL
HIV	NULL
LTR	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
same	NULL
mecha-nisms	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
results	NULL
,	NULL
we	NULL
have	NULL
begun	NULL
to	NULL
assess	NULL
the	NULL
amount	NULL
of	NULL
HIV	NULL
replication	NULL
that	NULL
is	NULL
occurring	NULL
in	NULL
these	NULL
subsets	NULL
in	NULL
vivo	NULL
.	NULL

Preliminary	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
completely	NULL
devoid	NULL
of	NULL
HIV	NULL
in	NULL
vivo	NULL
(	NULL
M.	NULL
Roederer	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Combined	NULL
with	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
,	NULL
this	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
CD3/CD28-stimulated	NULL
ex	NULL
vivo	NULL
expansion	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
HIV-infected	NULL
adults	NULL
leads	NULL
to	NULL
eradication	NULL
of	NULL
virus	NULL
from	NULL
the	NULL
cultures	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Specifically	NULL
:	NULL
CD3/CD28	NULL
stimulation	NULL
preferentially	NULL
expands	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
since	NULL
they	NULL
have	NULL
a	NULL
greater	NULL
proliferative	NULL
response	NULL
)	NULL
;	NULL
the	NULL
relative	NULL
lack	NULL
of	NULL
virus	NULL
in	NULL
these	NULL
cells	NULL
combined	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
suppress	NULL
extant	NULL
virus	NULL
leads	NULL
to	NULL
progressive	NULL
dilution	NULL
of	NULL
HIV	NULL
.	NULL

Levine	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
the	NULL
CD3/CD28	NULL
ex	NULL
vivo	NULL
expansion	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
might	NULL
be	NULL
useful	NULL
as	NULL
an	NULL
immune-based	NULL
cell	NULL
therapy	NULL
for	NULL
HIV	NULL
disease	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
supports	NULL
their	NULL
observations	NULL
and	NULL
suggestion	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
selective	NULL
expansion	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
population	NULL
of	NULL
cells	NULL
prerequisite	NULL
for	NULL
novel	NULL
immune	NULL
responses	NULL
,	NULL
is	NULL
desirable	NULL
for	NULL
immunological	NULL
restoration	NULL
in	NULL
immu-nodeficient	NULL
patients	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
data	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
resistant	NULL
to	NULL
HIV	NULL
in	NULL
vitro	NULL
and	NULL
are	NULL
uninfected	NULL
in	NULL
vivo	NULL
rules	NULL
out	NULL
direct	NULL
killing	NULL
by	NULL
HIV	NULL
as	NULL
the	NULL
mechanism	NULL
accounting	NULL
for	NULL
the	NULL
preferential	NULL
loss	NULL
of	NULL
this	NULL
subset	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
progression	NULL
of	NULL
HIV	NULL
disease	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
since	NULL
naive	NULL
CD8	NULL
T	NULL
cells	NULL
are	NULL
lost	NULL
at	NULL
the	NULL
same	NULL
rate	NULL
as	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
thymopoiesis	NULL
is	NULL
progressively	NULL
(	NULL
or	NULL
ab-solutely	NULL
)	NULL
destroyed	NULL
early	NULL
in	NULL
HIV	NULL
disease	NULL
.	NULL

Thus	NULL
,	NULL
long	NULL
term	NULL
therapy	NULL
of	NULL
HIV	NULL
disease	NULL
should	NULL
include	NULL
strategies	NULL
aimed	NULL
at	NULL
restoring	NULL
thymopoiesis	NULL
.	NULL

Woods	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
report	NULL
that	NULL
naive	NULL
,	NULL
but	NULL
not	NULL
memory	NULL
,	NULL
CD4	NULL
T	NULL
cells	NULL
show	NULL
a	NULL
loss	NULL
in	NULL
inducible	NULL
virus	NULL
after	NULL
infection	NULL
by	NULL
HIV	NULL
.	NULL

While	NULL
using	NULL
a	NULL
substantially	NULL
different	NULL
stimulation	NULL
from	NULL
ours	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
a	NULL
monokine	NULL
supernatant	NULL
)	NULL
,	NULL
their	NULL
findings	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
conclusions	NULL
of	NULL
our	NULL
paper	NULL
.	NULL

Together	NULL
,	NULL
our	NULL
reports	NULL
provide	NULL
strong	NULL
evidence	NULL
that	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
inherently	NULL
resistant	NULL
to	NULL
productive	NULL
HIV	NULL
infection	NULL
after	NULL
physiological	NULL
stimulation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Thomas	NULL
Schall	NULL
for	NULL
collaboration	NULL
on	NULL
the	NULL
chemokine-induced	NULL
calcium	NULL
flux	NULL
experiments	NULL
,	NULL
Tatiana	NULL
Auer	NULL
for	NULL
performing	NULL
the	NULL
quantitative	NULL
PCR	NULL
assays	NULL
for	NULL
HIV	NULL
,	NULL
and	NULL
Dr.	NULL
Ned	NULL
Landau	NULL
for	NULL
sharing	NULL
data	NULL
on	NULL
chemokine	NULL
receptor	NULL
expression	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Thomas	NULL
Merigan	NULL
for	NULL
making	NULL
available	NULL
the	NULL
facilities	NULL
of	NULL
the	NULL
Stanford	NULL
Center	NULL
for	NULL
AIDS	NULL
Research	NULL
facility	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

Peter	NULL
Katsikis	NULL
and	NULL
Rachel	NULL
Gerstein	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Herzenberg	NULL
laboratory	NULL
for	NULL
advice	NULL
and	NULL
help	NULL
,	NULL
and	NULL
to	NULL
Dr.	NULL
David	NULL
Parks	NULL
and	NULL
the	NULL
Stanford	NULL
Shared	NULL
Fluorescence	NULL
Activated	NULL
Cell	NULL
Sorter	NULL
Facility	NULL
for	NULL
expert	NULL
flow	NULL
cytometry	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
CA-42509	NULL
,	NULL
AT-31770	NULL
,	NULL
and	NULL
LM-04836	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Sanders	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
M.W	NULL
.	NULL

Makgoba	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

9:195-199	NULL
.	NULL

2	NULL
.	NULL

Picker	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Treer	NULL
,	NULL
D.	NULL
Ferguson	NULL
,	NULL
P.	NULL
Collins	NULL
,	NULL
D.	NULL
Buck	NULL
,	NULL
and	NULL
L.	NULL
Terstappen	NULL
.	NULL

1993	NULL
.	NULL

Control	NULL
of	NULL
lymphocyte	NULL
recirculation	NULL
in	NULL
man	NULL
.	NULL

I	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
peripheral	NULL
lymph	NULL
node	NULL
homing	NULL
receptor	NULL
L-selectin	NULL
on	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
virgin	NULL
to	NULL
memory	NULL
cell	NULL
transition	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:1105-1121	NULL
.	NULL

3	NULL
.	NULL

Okumura	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Fujii	NULL
,	NULL
K.	NULL
Takeuchi	NULL
,	NULL
K.	NULL
Inada	NULL
,	NULL
K.	NULL
Nakahara	NULL
,	NULL
and	NULL
H.	NULL
Mat-suda	NULL
.	NULL

1993	NULL
.	NULL

Age-related	NULL
accumulation	NULL
of	NULL
LFA-1	NULL
``	NULL
*	NULL
``	NULL
cells	NULL
in	NULL
a	NULL
CD8+	NULL
CD4SRA	NULL
``	NULL
®	NULL
``	NULL
T	NULL
cell	NULL
population	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:1057-1063	NULL
.	NULL

4	NULL
.	NULL

Schnittman	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Lane	NULL
,	NULL
J.	NULL
Greenhouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Preferential	NULL
infection	NULL
of	NULL
CD4+	NULL
memory	NULL
T	NULL
cells	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
in	NULL
the	NULL
selective	NULL
T-cell	NULL
functional	NULL
defects	NULL
observed	NULL
in	NULL
individuals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:6058-6062	NULL
.	NULL

5	NULL
.	NULL

Cayota	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Vuillier	NULL
,	NULL
F.	NULL
Scott-Algara	NULL
,	NULL
and	NULL
G.	NULL
Dighiero	NULL
.	NULL

1990	NULL
.	NULL

Preferential	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
the	NULL
memory	NULL
CD4+	NULL
subpopulation	NULL
in	NULL
asymptomatic	NULL
HIV-seropositive	NULL
patients	NULL
.	NULL

Lancet	NULL
(	NULL
N.	NULL
Am	NULL
.	NULL

Ed	NULL
.	NULL
)	NULL

.	NULL

336:941-942	NULL
.	NULL

6	NULL
.	NULL

Cayota	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Vuillier	NULL
,	NULL
D.	NULL
Scott-Algara	NULL
,	NULL
V.	NULL
Feuillie	NULL
,	NULL
and	NULL
G.	NULL
Dighiero	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
requirements	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
naive	NULL
and	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
asymptomatic	NULL
HIV-1	NULL
seropositive	NULL
carriers	NULL
and	NULL
AIDS	NULL
patients	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

91:241-248	NULL
.	NULL

7	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
J.G	NULL
.	NULL

Dubs	NULL
,	NULL
M.T	NULL
.	NULL

Anderson	NULL
,	NULL
P.A	NULL
.	NULL

Raju	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1995	NULL
.	NULL

CD8	NULL
naive	NULL
T	NULL
cell	NULL
counts	NULL
decrease	NULL
progressively	NULL
in	NULL
HIV-infected	NULL
adults	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:2061-2066	NULL
.	NULL

8	NULL
.	NULL

Levine	NULL
,	NULL
B.	NULL
,	NULL
J.D	NULL
.	NULL

Mosca	NULL
,	NULL
J.L	NULL
.	NULL

Riley	NULL
,	NULL
R.G	NULL
.	NULL

Carroll	NULL
,	NULL
MT	NULL
.	NULL

Vahey	NULL
,	NULL
LL	NULL
.	NULL

Ja-godzinski	NULL
,	NULL
K.F	NULL
.	NULL

Wagner	NULL
,	NULL
D.L	NULL
.	NULL

Mayers	NULL
,	NULL
D.S	NULL
.	NULL

Burke	NULL
,	NULL
O.S	NULL
.	NULL

Weislow	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Antiviral	NULL
effect	NULL
and	NULL
ex	NULL
vivo	NULL
CD4+	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
HIV-positive	NULL
patients	NULL
as	NULL
a	NULL
result	NULL
of	NULL
CD28	NULL
costimulation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

272:1939-1943	NULL
.	NULL

9	NULL
.	NULL

Azuma	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Cayabyab	NULL
,	NULL
D.	NULL
Buck	NULL
,	NULL
J.H	NULL
.	NULL

Phillips	NULL
,	NULL
and	NULL
L.L	NULL
.	NULL

Lanier	NULL
.	NULL

1993	NULL
.	NULL

CD28	NULL
interaction	NULL
with	NULL
B7	NULL
co-stimulates	NULL
primary	NULL
allogeneic	NULL
proliferative	NULL
responses	NULL
and	NULL
cytotoxicity	NULL
mediated	NULL
by	NULL
small	NULL
,	NULL
resting	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:353	NULL
.	NULL

10	NULL
.	NULL

Schmid	NULL
,	NULL
I.	NULL
,	NULL
CH	NULL
.	NULL

Uittenbogaart	NULL
,	NULL
and	NULL
J.V	NULL
.	NULL

Giorgi	NULL
.	NULL

1994	NULL
.	NULL

Sensitive	NULL
method	NULL
for	NULL
measuring	NULL
apoptosis	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
in	NULL
human	NULL
thymocytes	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cytometry	NULL
.	NULL

15:12-20	NULL
.	NULL

11	NULL
.	NULL

Folks	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
K.A	NULL
.	NULL

Clouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
J.H	NULL
.	NULL

Kehrl	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
T-cell	NULL
clone	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:2365-2368	NULL
.	NULL

12	NULL
.	NULL

Raju	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
M.	NULL
Roederer	NULL
.	NULL

1994	NULL
.	NULL

Glutathione	NULL
precursor	NULL
and	NULL
antioxidant	NULL
activities	NULL
of	NULL
N-acetylcysteine	NULL
and	NULL
oxa-thiazolidine	NULL
carboxylate	NULL
compared	NULL
in	NULL
in	NULL
vitro	NULL
studies	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
.	NULL

10:961-967	NULL
.	NULL

13	NULL
.	NULL

Piatak	NULL
,	NULL
M.	NULL
,	NULL
Jr.	NULL
,	NULL
K.C	NULL
.	NULL

Luk	NULL
,	NULL
B.	NULL
Williams	NULL
,	NULL
and	NULL
J.D	NULL
.	NULL

Lifson	NULL
.	NULL

1993	NULL
.	NULL

Quantitative	NULL
competitive	NULL
polymerase	NULL
chain	NULL
reaction	NULL
for	NULL
accurate	NULL
quantitation	NULL
of	NULL
HIV	NULL
DNA	NULL
and	NULL
RNA	NULL
species	NULL
.	NULL

Biotechniques	NULL
.	NULL

14:70-81	NULL
.	NULL

14	NULL
.	NULL

Mulder	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
McKinney	NULL
,	NULL
C.	NULL
Christopherson	NULL
,	NULL
J.	NULL
Sninsky	NULL
,	NULL
L.	NULL
Greenfield	NULL
,	NULL
and	NULL
S.	NULL
Kwok	NULL
.	NULL

1994	NULL
.	NULL

Rapid	NULL
and	NULL
simple	NULL
PCR	NULL
assay	NULL
for	NULL
quantitation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
RNA	NULL
in	NULL
plasma	NULL
:	NULL
application	NULL
to	NULL
acute	NULL
retroviral	NULL
infection	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

32:292-300	NULL
.	NULL

15	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
F.J.T	NULL
.	NULL

Staal	NULL
,	NULL
P.A	NULL
.	NULL

Raju	NULL
,	NULL
S.W	NULL
.	NULL

Ela	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

Cytokine-stimulated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
is	NULL
inhibited	NULL
by	NULL
N-acetyl-L-cysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87	NULL
:	NULL
4884-4888	NULL
.	NULL

16	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1991	NULL
.	NULL

FACS-Gal	NULL
:	NULL
flow	NULL
cytometric	NULL
analysis	NULL
and	NULL
sorting	NULL
of	NULL
cells	NULL
expressing	NULL
reporter	NULL
gene	NULL
constructs	NULL
.	NULL

Methods	NULL
(	NULL
Orlando	NULL
)	NULL
.	NULL

2:248-260	NULL
.	NULL

17	NULL
.	NULL

Fried	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.M	NULL
.	NULL

Crothers	NULL
.	NULL

1981	NULL
.	NULL

Equilibria	NULL
and	NULL
kinetics	NULL
of	NULL
lac	NULL
re-pressor-operator	NULL
interactions	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9:6505-6525	NULL
.	NULL

18	NULL
.	NULL

Garner	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
and	NULL
A.	NULL
Revzin	NULL
.	NULL

1981	NULL
.	NULL

A	NULL
gel	NULL
electrophoresis	NULL
method	NULL
for	NULL
quantifying	NULL
the	NULL
binding	NULL
proteins	NULL
to	NULL
specific	NULL
DNA	NULL
regions	NULL
:	NULL
application	NULL
to	NULL
components	NULL
of	NULL
the	NULL
Escherichia	NULL
coli	NULL
lactose	NULL
operon	NULL
system	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

9	NULL
:	NULL
3047-3060	NULL
.	NULL

19	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Bigos	NULL
,	NULL
T.	NULL
Nozaki	NULL
,	NULL
R.T.	NULL
Stovel	NULL
,	NULL
D.R	NULL
.	NULL

Parks	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1995	NULL
.	NULL

Heterogeneous	NULL
calcium	NULL
flux	NULL
in	NULL
peripheral	NULL
T	NULL
cell	NULL
subsets	NULL
revealed	NULL
by	NULL
five-color	NULL
flow	NULL
cytometry	NULL
using	NULL
log-ratio	NULL
circuitry	NULL
.	NULL

Cytometry	NULL
.	NULL

21:187-196	NULL
.	NULL

20	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

326:711-713	NULL
.	NULL

21	NULL
.	NULL

Feng	NULL
,	NULL
Y.	NULL
,	NULL
C.C	NULL
.	NULL

Broder	NULL
,	NULL
P.E	NULL
.	NULL

Kennedy	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Berger	NULL
.	NULL

1996	NULL
.	NULL

HIV-1	NULL
entry	NULL
cofactor	NULL
:	NULL
functional	NULL
cDNA	NULL
cloning	NULL
of	NULL
a	NULL
seven-transmembrane	NULL
,	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

272:872-877	NULL
.	NULL

22	NULL
.	NULL

Deng	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Liu	NULL
,	NULL
W.	NULL
Ellimeier	NULL
,	NULL
S.	NULL
Choe	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
M.	NULL
Burkhart	NULL
,	NULL
P.D	NULL
.	NULL

Marzio	NULL
,	NULL
S.	NULL
Marmon	NULL
,	NULL
R.E	NULL
.	NULL

Sutton	NULL
,	NULL
C.M	NULL
.	NULL

Hill	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
major	NULL
co-receptor	NULL
for	NULL
primary	NULL
isolates	NULL
of	NULL
HIV-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

381:661-666	NULL
.	NULL

23	NULL
.	NULL

Dragic	NULL
,	NULL
T.	NULL
,	NULL
V.	NULL
Litwin	NULL
,	NULL
G.P	NULL
.	NULL

Allaway	NULL
,	NULL
S.R	NULL
.	NULL

Martin	NULL
,	NULL
Y.	NULL
Huang	NULL
,	NULL
K.A	NULL
.	NULL

Na-gashima	NULL
,	NULL
C.	NULL
Cayana	NULL
,	NULL
P.J	NULL
.	NULL

Maddon	NULL
,	NULL
R.A.	NULL
Koup	NULL
,	NULL
J.P.	NULL
Moore	NULL
,	NULL
and	NULL
W.A	NULL
.	NULL

Paxton	NULL
.	NULL

1996	NULL
.	NULL

HIV-1	NULL
entry	NULL
into	NULL
CD4+	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
chemokine	NULL
receptor	NULL
CC-CKR-5	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

381:667-673	NULL
.	NULL

24	NULL
.	NULL

Alkhatib	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
Combadiere	NULL
,	NULL
C.C	NULL
.	NULL

Broder	NULL
,	NULL
Y.	NULL
Feng	NULL
,	NULL
P.E	NULL
.	NULL

Kennedy	NULL
,	NULL
P.M.	NULL
Murphy	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Berger	NULL
.	NULL

1996	NULL
.	NULL

CC	NULL
CKRS5	NULL
:	NULL
A	NULL
RANTES	NULL
,	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-18	NULL
receptor	NULL
as	NULL
a	NULL
fusion	NULL
cofactor	NULL
for	NULL
macrophage-tropic	NULL
HIV-1	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

272:1955-1958	NULL
.	NULL

25	NULL
.	NULL

Doranz	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
J.	NULL
Rucker	NULL
,	NULL
Y.	NULL
Yi	NULL
,	NULL
R.J.	NULL
Smyth	NULL
,	NULL
M.	NULL
Samson	NULL
,	NULL
S.C.	NULL
Peiper	NULL
,	NULL
M.	NULL
Parmentier	NULL
,	NULL
R.G	NULL
.	NULL

Collman	NULL
,	NULL
and	NULL
R.W	NULL
.	NULL

Doms	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
dual-tropic	NULL
primary	NULL
HIV-1	NULL
Naive	NULL
CD4	NULL
T	NULL
Cells	NULL
Suppress	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
1563	NULL
isolate	NULL
that	NULL
uses	NULL
fusin	NULL
and	NULL
the	NULL
beta-chemokine	NULL
receptors	NULL
CKR-5	NULL
,	NULL
CKR-3	NULL
,	NULL
and	NULL
CKR-2b	NULL
as	NULL
fusion	NULL
cofactors	NULL
.	NULL

Cell	NULL
.	NULL

85:1149-1158	NULL
.	NULL

26	NULL
.	NULL

Choe	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Farzan	NULL
,	NULL
Y	NULL
.	NULL

Sun	NULL
,	NULL
N.	NULL
Sullivan	NULL
,	NULL
B.	NULL
Rollins	NULL
,	NULL
P.D	NULL
.	NULL

Ponath	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
C.R	NULL
.	NULL

Mackay	NULL
,	NULL
G.	NULL
LaRosa	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
beta-chemokine	NULL
receptors	NULL
CCR3	NULL
and	NULL
CCRS	NULL
facilitate	NULL
infection	NULL
by	NULL
primary	NULL
HIV-1	NULL
isolates	NULL
.	NULL

Cell	NULL
.	NULL

85:1135-1148	NULL
.	NULL

27	NULL
.	NULL

Bleul	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
M.	NULL
Farzan	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
C.	NULL
Parolin	NULL
,	NULL
I.	NULL
Clarklewis	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
T.A	NULL
.	NULL

Springer	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
lymphocyte	NULL
chemoattractant	NULL
SDF-1	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
blocks	NULL
HIV-1	NULL
entry	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

382:829-833	NULL
.	NULL

28	NULL
.	NULL

Oberlin	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Amara	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.L	NULL
.	NULL

Virelizier	NULL
,	NULL
F.	NULL
Aren-zanaseisdedos	NULL
,	NULL
O.	NULL
Schwartz	NULL
,	NULL
J.M	NULL
.	NULL

Heard	NULL
,	NULL
I.	NULL
Clarklewis	NULL
,	NULL
D.F	NULL
.	NULL

Legler	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
CXC	NULL
chemokine	NULL
SDF-1	NULL
is	NULL
the	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
prevents	NULL
infection	NULL
by	NULL
T-cell-line-adapted	NULL
HIV-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

382:833-835	NULL
.	NULL

1564	NULL
_	NULL
Roederer	NULL
etal	NULL
.	NULL

29	NULL
.	NULL

Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Hamamoto	NULL
,	NULL
N.	NULL
Yamamoto	NULL
,	NULL
A.	NULL
Ishii	NULL
,	NULL
M.	NULL
Yonehara	NULL
,	NULL
and	NULL
S.	NULL
Yonehara	NULL
.	NULL

1990	NULL
.	NULL

Anti-Fas	NULL
monoclonal	NULL
antibody	NULL
is	NULL
cytocidal	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
cells	NULL
without	NULL
augmenting	NULL
viral	NULL
replication	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9620-9624	NULL
.	NULL

30	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
P.A	NULL
.	NULL

Raju	NULL
,	NULL
F.J.T	NULL
.	NULL

Staal	NULL
,	NULL
L.A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1991	NULL
.	NULL

N-Acetylcysteine	NULL
inhibits	NULL
latent	NULL
HIV	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
.	NULL

7:563-567	NULL
.	NULL

31	NULL
.	NULL

Woods	NULL
,	NULL
T.	NULL
,	NULL
B.D	NULL
.	NULL

Roberts	NULL
,	NULL
S.T	NULL
.	NULL

Butera	NULL
,	NULL
and	NULL
TM	NULL
.	NULL

Folks	NULL
.	NULL

1997	NULL
.	NULL

Loss	NULL
of	NULL
inducible	NULL
virus	NULL
in	NULL
CD4SRA	NULL
naive	NULL
cells	NULL
after	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
entry	NULL
accounts	NULL
for	NULL
preferential	NULL
viral	NULL
replication	NULL
in	NULL
CD4S5RO	NULL
memory	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

89:1635-1642	NULL
.	NULL

